



Total Synthesis of the Polyketide Natural Product (−)-Pironetin and Studies Directed Toward 










A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the 



























































Anne-Marie Roe Dechert Schmitt 










Anne-Marie Roe Dechert Schmitt: 
Total Synthesis of the Polyketide Natural Product (−)-Pironetin and Studies Directed Toward 
the Total Synthesis of Iriomoteolide 1a. 
(Under the direction of Professor Michael T. Crimmins) 
 
 Polyketides are secondary metabolites with diverse structural scaffolds.  The 
research summarized herein describes the biomimetic total synthesis of the polyketide (−)-
pironetin utilizing iterative aldol additions of thiazolidinethiones to create five of the six total 
stereocenters of (−)-pironetin.  This technology has also been applied to a convergent 
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Total Synthesis of ( −)-Pironetin  
A. Introduction 
1. Isolation and Biological Significance 
  (−)-Pironetin (1, Figure 1.1) is a polyketide natural 
product that was independently isolated in 1994 by both the 
Yoshida and Kobayashi groups from the Streptomyces sp. 
NK10958a.1  Structurally, (−)-pironetin consists of an α,β-
unsaturated δ lactone possessing a linear alkyl chain containing four contiguous 
stereocenters and a trans-olefin.  Initially determined to be a plant growth regulator1b, (−)-
pironetin was also identified as having both immunosuppressant activity and antiproliferative 
activity against several tumor cell lines, including murine tumor cell line P388 leukemia (20 
ng/mL), HeLa (10 ng/mL), A2780 (10 ng/mL), and K-NRK (10 ng/mL).2  Further examination 
of (−)-pironetin and its demethyl derivative (2, Figure 1.1), have shown that cell cycle 
progression is inhibited at the M-phase, which is where cells are most sensitive to radiation 
and DNA alkylating compounds.2  Investigation of the mechanism of action has revealed 
that pironetin is a potent inhibitor of tubulin assembly, by way of a covalent binding 
interaction between the Lys352 of α−tubulin with the α,β−unsaturated δ lactone of (−)-


























 Though (−)-pironetin shows moderate effects against the tumor cell lines mentioned 
above and toxicity in vivo, it is viewed as a potential lead compound for the development of 
cancer therapeutics due to its structural simplicity compared to other notable tubulin binding 







 Polyketides represent an important class of natural products due to their wealth of 


























endeavor, several groups have developed methods to construct polyketide frameworks, and 
have applied these methods in the context of the total synthesis of (−)-pironetin.6   
 
2. Previous Syntheses  
2.1 Kawada's approach to ( −)-pironetin 
 The first total synthesis of (−)-pironetin was reported by Kawada and co-workers in 
1995.6a Kawada's convergent approach relied on a Wittig olefination of aldehyde 3 and 
phosphonium salt 4 to form the C6-C7 bond (Scheme 1.1).  Aldehyde 3 would be derived 
from commercially available glucopyranoside 5, which contains the correct configuration at 
C5, while phosphonium salt 4 takes advantage of the chiral pool by employing the (S)-








 Beginning with commercially available glucopyranoside 5, in a series of four steps 
involving formation of the dimesylate, opening of the acetal, protection, and epoxide 
formation, epoxide 7 was formed in 53% over four steps (Scheme 1.2).  Opening of the 
epoxide with EtMgCl in the presence of CuCl delivered the expected axial alcohol 8, with 











































were protected as the benzyl ethers, the TBDPS ether was cleaved, and the resultant 









 Phosphonium salt fragment 4 was prepared in eleven steps from (S)-Roche ester 
(6), beginning with a protection of the primary alcohol as the benzyl ether, and a four step 
manipulation of the methyl ester to form allylic alcohol 9 (Scheme 1.3).  At this point, an 
epoxidation of allylic alcohol 9 with m-CPBA takes advantage of A1,3-strain minimization to 
form the epoxide with the correct orientation at C9.  Hydroxyl directed opening of the 



































































































protected as the TBDPS ether, the secondary alcohol was methylated, and the benzyl ether 
was transformed into phosphonium salt 4.  A Wittig olefination between aldehyde 3 and 
phosphonium salt 4 formed the C6-C7 bond, to generate olefin 11.  However, to complete 
the synthesis, an additional 13 steps were necessary for both protecting group and 
functional group manipulations, generating the natural product in 27 linear steps and 1% 
overall yield.  Kawada's approach represents the first total synthesis of (−)-pironetin, and 
confirmed the absolute stereochemistry of the natural product.                  
 
2.2 Nelson's approach to ( −)-pironetin 
 Nelson's approach to (−)-pironetin showcases the acyl-halide aldehyde 
cyclocondensation (AAC) reactions developed in his laboratory.6k  Beginning with easily 
prepared aldehyde 12 and propionyl chloride 13 (Scheme 1.4), Nelson utilizes the catalysts 












































 To form β-lactone 16, aldehyde 12, prepared in two steps from 1,3 propane diol, 
underwent an AAC reaction with catalyst 14 and propionyl chloride to furnish 16 in 90% 
yield, 99% ee, and 89:11 syn/anti ratio (Scheme 1.5).  The stereoselectivity of this reaction 

















 In two additional acyl-halide aldehyde cyclocondensation iterations, all six 
stereocenters of pironetin were formed in a modular fashion, in both high yield and high d.r. 
to arrive at β-lactone 18.  Opening of the β-lactone, cleavage of the silyl protecting group, 
and formation of the 2-pyranone unit was accomplished in three steps, generating pironetin 
in 17 total steps and 5% overall yield.  This AAC approach to polypropionate units 







































































represents a useful variant in aldol chemistry, generating polypropionate subunits in the 
absence of chiral auxiliaries, catalytically, and in an iterative fashion.  
 
2.3 Enders' approach to ( −)-pironetin  
 Enders approach to pironetin relied on the formation of three of the six stereocenters 
of (−)-pironetin utilizing RAMP/SAMP hydrazone alkylation and aldolization methodlogy.6l  
Hence, formation of pironetin would occur in a convergent manner from aldehyde 19 and 







 Construction of enol silane 20, began with an alkylation of hydrazone 21, followed by 
removal of the auxiliary under acidic conditions to reveal silyl enol ether 20 in 78% yield and 
98% ee over 2 steps (Scheme 1.7). 





 To form the stereocenters at C4 and C5, an asymmetric hydrazone aldol employing 
butanal RAMP hydrazone 22, and aldehyde 23 generated aldol adduct 24 in 80%, 55% de, 



















steps involving protecting group and functional group manipulations, aldehyde 19 was 
prepared.       
 
 Aldehyde fragment 19 and silyl enol ether fragment 20 were united through a 
Mukaiyama aldol, giving a mixture of diastereomers, favoring the desired aldol adduct 25 in 
57% isolated yield (Scheme 1.9).  A Tishchenko reduction of resultant ketone 25 generated 
secondary alcohol 26 which contains all 6 stereocenters of pironetin.  In seven additional 









2.4 Cossy's Approach 
 Cossy's approach to (−)-pironetin relied on allylation chemistry to form 5 of the 6 
stereocenters of pironetin.6m  It also, as other approaches have done, takes advantage of 
the chiral pool by utilizing the (S)-Roche ester (6), which contains the correct configuration at 


























































 The synthesis began with a two step sequence to form aldehyde 27, which was then 
subjected to a diastereoselective crotylation utilizing Ti-TADDOL-complex 28, to generate 
secondary alcohol 29 in 95:5 d.r. and 60% yield over 3 steps (Scheme 1.11).  Subsequent 
methylation and ozonolysis delivered aldehyde 30, which underwent an asymmetric 
allylation employing Ti-TADDOL-complex 31 to provide secondary alcohol 32 in 95:5 d.r. 
and 50% yield over 3 steps.  In four steps, the tosylate was transformed into an internal 
alkyne, and the olefin was selectively cleaved to form aldehyde 33.  A highly stereselective 
boron-mediated pentenylation, followed by acylation with acryloyl chloride yields dienyne 34.   
 In a single pot operation, dienyne 34 was hydrosilylated under Trost's conditions, 
RCM of the resultant triene forms the δ-lactone, and treatment with AgF leads to 
protodesilylation to provide the E-olefin present in the natural product.  Deprotection of the 








































3. Use of the thiazolidinethione to access polyketid e subunits 
3.1 Biosynthesis of polyketides 
 Polyketides are structurally diverse secondary metabolites of plants, animals, fungus, 
or bacteria; and as such, possess a wealth of pharmacological activity, including anti-
cancer, antibiotic, immunosupressent, and antifungal properties.  Though polyketides are 
structurally diverse and have differing molecular complexity, the origin of these compounds 
is related through their biosynthesis.5 In the biosynthesis of polyketides, a "starter unit" (35) 





























































ii. [Cp*Ru(MeCN)3]PF6 (1 mol %)
iii. Grubbs II (5 mol %)
2. AgF
64% for 2 steps
(-)-pironetin
14 steps , 8.2% overall




Scheme 1.11 : Cossy's total synthesis of (-)-pironetin.
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extensions with a -CHR-CO- "extender units" (36) (Scheme 1.12).5  The starter unit is 
commonly derived from acetyl-CoA or propionyl-CoA, while the extender units are 
derivatives of malonic acid or a malonic acid thioester.5  Extension of the starter unit occurs 
via a condensation reaction involving decarboxylation of the malonate extender units.  
Enzymes which are responsible for building the initial polyketide chain are known as 
polyketides synthases (PKS), and during the process of chain formation, the resultant 
carbonyl group may be transformed by the aid of enzymes, or retain its identity.5  Some 
examples of enzymes that facilitate the production of polyketides include ketoreductases 
(KR) which reduce carbonyls to alcohols, dehydratases (DH) which eliminate alcohols to 
form olefins, and enoylreductases (ER) which reduces olefins to alkanes.5 
 
 
3.2 Thiazolidinethione technology in the context of total synthesis 
 It was conceived that the use of different variants of titanium tetrachloride mediated 
aldol additions of N-acylthiazolidinethiones and aldehydes or acetals would allow for (-)-
pironetin to be synthesized in a "biomimetic" approach.  In this approach, C-C bond 
formation would occur via a highly diastereoselective aldol reaction utilizing a 
12 
 
thiazolidinethione chiral auxiliary 37 to form aldol adduct 38, which could be followed by 
protection of the resultant hydroxyl, and cleavage of the chiral auxiliary directly to aldehyde 
39 that could be utilized in a second aldol iteration with thioimide 37 (Scheme 1.13).  Use of 
the thiazolidinethione allows the entire process (C-C bond formation, protection, reduction to 
the aldehyde) to be accomplished in only three steps.  Compared to the use of an 
oxazolidinone chiral auxiliary in an asymmetric aldol, the use of a thiazoldinethione chiral 
auxiliary represents a more direct approach as the aldol adduct of an oxazolidinone cannot 
be converted directly to an aldehyde.  This strategy has previously been applied to the 









 Several years ago, the Crimmins group disclosed a method to access both Evans 
syn and non-Evans syn aldol adducts from the same antipode of acyl thiazolidinethiones 37, 
simply by varying the nature and equivalents of the amine base that is employed.9  To 
access non-Evans syn products, the N-acylthiazolidinethione (37) is treated with one 
equivalent of titanium tetrachloride, one equivalent of an amine base, and one equivalent of 
an aldehyde.9  The reaction is believed to proceed through the formation of steric-minimized 
chelated chair-like transition state 40, in which the nucleophilic thiocarbonyl chelates to the 
titanium metal center giving rise to non-Evans syn adduct 41.9  Alternatively, the use of two 











































obtained in high diastereoselectivities.9  This result is rationalized through a dipole and steric 
minimized transition state 43, in which the extra equivalent of (−)-sparteine or NMP is 













 Compared to the propionate aldol, the acetate aldol reaction has been more difficult 
to render highly diastereoselective with the same thiazolidinethione and oxazolidinone chiral 
auxiliaries, due to the lack of substitution on the α carbon.  Mariam Shamszad, a former 
graduate student in the Crimmins lab, developed a highly diastereoselective acetate aldol 
addition utilizing a bulky mesityl substituted thiazolidinethione (Figure 1.5).10 Treatment of 
thiazolidinethione 44 with one equivalent of TiCl4, one equivalent of Hünig's base, and one 
equivalent of an aldehyde generates aldol adduct 45 in high diastereoeselctivity, which is 
believed to arise through the formation of a chelated six membered chair-like transition state 
46, in which the bulky mesityl group forces the R group of the aldehyde into a pseudo-





























































of the mesityl.10  Another possible transition state (47) is also depicted in figure 1.5, in which 











 Direct access to the anti propionate aldol adduct utilizing alkyl substrates is not 
currently possible using the chlorotitanium enolates of N-acylthiazolidinethiones, and often 
requires expensive chiral auxiliaries or Lewis acids with other chiral auxiliary based 
approaches or exotic catalysts for non-auxiliary based approaches.11  These approaches are 
not always convienent or widely applicable to a broad array of substrates.  Evans and 
coworkers have developed an anti aldol reaction to access anti β-hydroxy aldol adducts 
utilizing magnesium enolates of oxazolidinones or thiazoldinethiones and various aromatic 
aldehydes (Figure 1.6).12  Although aromatic aldehydes in combination with N-
acylthiazolidinethiones give highly diastereoselective aldol adducts in high yields using this 
method, aliphatic aldehydes give significantly lower conversion.  In this context, Mg 
facilitates formation of the Z-enolate of thioimide 37, and the reaction is thought to proceed 
through a dipole minimized boat-like transition state 48 to form a magnesium aldolate, which 
is irreversibly trapped by trimethylsilyl chloride to form the product 49, and regenerate the 


















































 Recently, Hoye and coworkers reported an extension of the Evans magnesium 
halide catalyzed anti aldol reaction employing aliphatic aldehydes and oxazolidinones.13   
Because the primary byproducts in these reactions and related reactions with N-acyl 
thiazolidinethiones stem from the instability of the aldehyde, through silyl enol ether 
formation or self-aldol reactions of the aldehyde, it was reasoned that the use of a 
stoichiometric amount of the magnesium halide would result in an increase in the amount of 
enolate present in the reaction.13  Furthermore, syringe pump addition of the aldehyde 
should result in a higher steady state enolate to aldehyde ratio, resulting in higher yields of 
the aldol adduct.13  However, the yields reported in these instances remain subpar. 
 A viable alternative to generate the anti propionate subunit is through an N-acyl 
thiazolidinethione mediated acetal aldol, developed by Urpi, which allows access to anti β-
alkoxy-α-methyl aldol adducts (Figure 1.7).14 The diasteroselection associated with the 
acetal aldol, though modest, is thought to arise through a dipole and steric-minimized open 
transition state 50 in which the in situ generated oxocarbenium ion undergoes addition from 
the less hindered face of a chelated Z enolate, in an antiperiplanar arrangement (Figure 1.7) 
leading to aldol adduct 51.14a  The minor diastereomer arises through transition state 52, 





 This acetal aldol addition of N-acylthiazolidinethiones is highly advantageous for two 
reasons: it gives rise to the anti subunit, and it circumvents an additional O-alkylation step. 
Alkylation of β−hydroxy carbonyls is difficult due to the tendency of these substrates to 
undergo retro-aldol cleavage under basic conditions.  Furthermore, the use of more reactive 
alkylating agents (methyl triflate and methyl fluorosulfonate), which do not require basic 
conditions, also readily alkylate biological tissues, and therefore represents a serious safety 
concern.  One key aspect that we wished to explore was the effect of other 
thiazolidinethiones on the diastereoselection of the acetal aldol addition.  It was thought that 
employing bulkier R group on chiral auxiliary 54 (Figure 1.7) would lead to formation of anti 
β-alkoxy-α-methyl aldol adducts in higher diastereoselection, and this highly 
diastereoselective reaction could be applied to the total synthesis of (−)-pironetin.   
   
B. Synthesis of ( −)-pironetin  

























































 The retrosynthetic analysis of (−)-pironetin is shown in scheme 1.14.  The synthesis 
of 1 relies on the formation of 5 out of 6 stereocenters through titanium tetrachloride 
mediated iterative aldol reactions utilizing the N-acylthiazolidinethione chiral auxiliary.  It was 
envisioned that the Z-enoate of 1 would arise through a modified Horner-Emmons reaction 
with aldehyde 55.  Aldehyde 55 would be synthesized via and Evans syn aldol reaction with 
aldehyde 56 and thiazolidinethione 57.  Aldehyde 56 could be accessed via a highly 
diastereoselective acetate aldol reaction between mesityl substituted thiazolidinethione 44 
and aldehyde 58.  Aldehyde 58, in turn, would result from a highly diastereoselective acetal 














































































2. Preparation of Acetal 59 
 Initial efforts to prepare acetal 59 centered on the use of an asymmetric alkylation 
employing crotyl bromide, propionamide 61, and LDA (Scheme 1.15) to form alkylated 
oxazolidinone 62.  The auxiliary would then be reductively cleaved, and the resultant alcohol 
oxidized to deliver an aldehyde, which could be stirred with methanol and catalytic acid to 
deliver acetal 59.  It was found that under alkylation conditions which utilized 90% trans 
crotyl bromide, a 2:1 mixture of E/Z isomers resulted from the reaction conditions.  This was 
attributed to isomerization of the crotyl bromide or product during the course of the reaction.  
 An alternative strategy to access 59 is outlined in scheme 1.16.  Beginning with 
propionate 61, an asymmetric alkylation employing allyl iodide delivered terminal olefin 63 in 
67% yield and 20:1 d.r.  A cross metathesis15 between terminal olefin 63, Grubbs' 1st 
generation catalyst, and propene gas was expected to deliver the crotylated product in 
higher E selectivity than what was obtained in the asymmetric alkylation.  The cross 
metathesis generated olefin 64 in 66% conversion and as a 5:1 mixture of E/Z isomers.  Due 
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 An alternative strategy to synthesize aldehyde 65, previously described by Evans, 
was instead employed in an effort to obtain acetal 59 (Scheme 1.17).  Treatment of 3-buten-
2-ol (66) with trimethyl orthoacetate and catalytic acid produced 67 in situ which underwent 
a Johnson-Claisen rearrangement to deliver isomerically pure ester 68.16  Ester 68 was 
saponified under basic conditions to form carboxylic acid 69, which was transformed into the 
mixed anhydride upon treatment with 70 and triethylamine, and displaced by the lithiated 
oxazolidinone 71 to deliver acylated oxazolidinone 72.   An asymmetric alkylation employing 
LDA was used to install the stereocenter at C-10.  Reductive cleavage of the oxazolindinone 
was affected utilizing LiAlH4 to afford alcohol 73, which was then oxidized under Swern 
conditions, and stirred in the presence of MeOH and p-TsOH to provide dimethyl acetal 59 
in 62% yield for 3 steps.  
 
Scheme 1.16 : Alternative approach to










































3. Attempts to improve the diastereoselectivity in the reaction of N-acyl 
thiazoldinethiones with dimethyl acetals 
 With dimethyl acetal 59 in hand, the key acetal aldol coupling was explored using a 
model system of benzaldehyde dimethyl acetal (74) and various thiazoldinethione chiral 
auxiliaries in attempts to improve the diastereoselection of the acetal aldol.  Prior work by 
Urpi has shown that the use of benzaldehyde dimethyl acetal (74) in conjuction with valine 
derived thiazolidinethione chiral auxiliaries (60) can lead to anti aldol adducts (75) with 
moderate diastereoselection (Table 1.1, entry 1).14a  Also formed in the reaction is the minor 





























































 It was initially speculated that the use of a thiazolidinethione chiral auxiliary with a bulkier R 
group, such as the mesityl substituted 
thiazolidinethione 77, would cause 
transition state 78 to be more favorable 
than transition state 79, and lead to the 
formation of aldol adduct 75 in higher 
diastereselectivities than what Urpi had 
obtained with the use of valine derived 
thiazoldienthione 60 (Figure 1.8).  However, the use of mesityl substiututed 
thiazoldinethione 77 caused a dramatic decrease in the diastereoselection under Urpi's 
conditions (Table 1.1, entry 2), which was likely due to an increased steric interaction 
between the E-oxocarbenium ion14a and the methyl groups of the mesityl (Figure 1.8).  Since 
the use of a bulky chiral auxiliary had resulted in a decrease in diastereoselection, it was 
reasoned that the use of a smaller R group on the thiazolidinethione, such as a methyl, may 
provide enough steric bulk to provide the necessary facial selectivity for C-C bond formation, 
but not cause an unfavorable steric interaction with the E-oxocarbenium in transition state 
78, as the mesityl thiazoldinethione 77 had likely caused.  A less sterically encumbered 
thiazolidinethione chiral auxiliary, 80, derived from L-alaninol and prepared according to Le 
Entry  R1 = Yield  75:76 
1 iPr 75% 87:13 
2 Mes 64% 67:33 
3 Me 64% 86:14 


























Corre's procedure17 was then used in the asymmetric acetal aldol with benzaldehyde 
dimethyl acetal.  This resulted in the formation of the products in an 86:14 ratio, which was 
not significantly different from what Urpi had reported (Table 1, entry 3). 
 
4. Completion of ( −)-pironetin 
 Instead of exploring the diastereoselectivity of the acetal aldol addition with 
chlorotitanium enolates of thiazolidinethiones further, the reaction conditions for the key 
acetal aldol reaction was probed employing dimethyl acetal 59 and valine derived thioimide 
60 to form 81.  Initial attempts to utilize BF3OEt2 as a Lewis acid generated the product in 
low yields.  Ultimately, SnCl4, a stronger Lewis acid, was found to significantly affect the 












enolate (2 equivalents), using one equivalent of SnCl4, and one equivalent of acetal 59 to 
generate aldol adduct 81 in 64% yield and 98:2 dr.  The temperature of the reaction also 
had a pronounced effect, as the best yields were obtained when the reaction was warmed to 
-20 °C immediately following the addition of SnCl 4 and dimethyl acetal 59. The high 
Reaction 
Temperature  Yield  
-78 °C 16% 
-50 °C 33% 



















diastereoselectivity observed in this case is explained by the presence of the α stereocenter 











 With aldol adduct 81 in hand, the auxiliary was reductively cleaved with i-Bu2AlH to 
afford aldehyde 58, which was immediately subjected to an acetate aldol reaction with 
thiazolidinethione 44 to afford alcohol 82 in 88% yield and 95:5 dr (Scheme 1.18).  An 
excess of the enolate (1.5 equiv) was necessary to achieve complete conversion of the 
aldehyde to the aldol adduct.  Protection of alcohol 82 as the triethylsilyl ether delivered 
thiazolidinethione 83.  Reductive removal of the auxiliary with i-Bu2AlH
18 furnished aldehyde 
56, which was then subjected to an Evans syn aldol reaction9 with thioimide 57, affording 





















Figure 1.9 : Explanantion of the high diastereselectivity





 With all six stereocenters of (−)-pironetin installed, the synthesis proceeded with 
silylation of alcohol 84 to provide triethylsilyl ether 85, which was then exposed to i-Bu2AlH 
to effect reductive cleavage of the chiral auxiliary affording aldehyde 55 (Scheme 1.19).  
Thus, three iterative aldol reactions allowed the incorporation of 5 of the 6 stereocenters of 
pironetin, affording aldehyde 55 in 8 steps from known acetal 59.  To complete the 
synthesis, aldehyde 55 was treated with excess phosphonate 86, to effect formation of Z-
α, β unsaturated ester 87 as a 10:1 mixture of Z/E isomers.19  Exposure of 87 to PPTS in 
10:1 CH2Cl2/MeOH provided only the unprotected diol; however, upon heating ester 87 with 
PPTS in 10:1 benzene/MeOH to 60 °C both silyl ether p rotecting groups were cleaved and 
lactonization was induced to furnish (−)-pironetin (1) in 63% yield.  Synthetic 1 was identical 






 In summary, the enantioselective total synthesis of (−)-pironetin was completed in 11 
steps from previously prepared aldehyde 65 with an overall yield of 12.5%.  Key steps 
include a highly diastereoselective acetal aldol addition, a highly diastereoselective acetate 
aldol addition, and a highly diastereoselective propionate Evans syn-aldol addition, all of 
which are controlled by thiazolidinethione chiral auxiliaries. The versatility of the 
chlorotitanium mediated asymmetric aldol reaction was demonstrated through an iterative 
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 Iriomoteolide 1a Background  
A.  Isolation and biological activity 
 Marine dinoflagellates of the Amphidinium species are recognized as an important 
source of structurally diverse macrolides, termed amphidinolides, with noteworthy biological 
activity.1  In the pursuit for new bioactive natural products, Tsuda and coworkers surveyed 
over 250 strains of the dinoflagellate sp. Amphidinium strain using a rapid identification 
technique known as one cell-PCR, which is based on identifiying a certain sequence of DNA 
that only macrolide producing Amphidinium strains possess.2  From this analysis, and 
subsequent cytotoxic screening and metabolic analysis, Amphidinium strain HYA024 was 
identified as a producer of novel macrolides.2  To date, four macrolides, iriomoteolide 1a 
(2.1), 1b (2.2), 1c (2.3), and 3a (2.4) have been isolated from strain HYA024, with three of 





















The structures and relative sterochemistry of the iriomoteolides were elucidated 
utilizing detailed 2D-NMR studies, while the absolute stereochemistry was assigned using a 
modified variant of Mosher's method.2-4  Iriomoteolide 1a was originally identified to be a 20-
membered macrolide, which contains three alcohols, one of which is tertiary.  Other 
structural attributes include a hemiketal embedded in a tetrahydropyran ring, an exocyclic 
olefin, and three endogenous olefins.2  Notably, iriomoteolide 1a was identified as the first 
isolated member from the amphidinolide family of natural products which possesses a Z-
olefin.2  Two other macrolides isolated, later identified as iriomoteolides 1b (2.2) and 1c 
(2.3), were also identified to contain a 20-membered macrocyclic ring system.3  Based on 
NMR data, iriomoteolide 1b is thought to have only a monocyclic ring system, and instead of 
a C9-C13 tetrahydropyran ring system, which iriomoteolide 1a possesess, iriomoteolide 1b 
contains a ketone at C13 in conjugation with an E alkene at C11-C12, and a free hydroxyl 
group at C9.3  Iriomoteolide 1c is thought to contain the same ring systems as iriomoteolide 
1a, but has a 4-hydroxy-3-methyl pentyl sidechain at C19 containing two unidentified 
































































Iriomoteolide 3a (2.4) was also isolated from strain HYA024, and is a 15-membered 
macrolide containing an allyl epoxide.4 
 Notably, iriomoteolide 1a exhibits potent cytotoxicity against the human B 
lymphocyte DG-75 cells (IC50 = 0.002 µg/mL), which is 20 times as potent as the anticancer 
therapeutic drug doxorubicin (IC50 = 0.04 µg/mL), and is one of the most cytotoxic 
macrolides isolated from the Amphidinium species to date.2  Iriomoteolide 1a has also been 
shown to possess potent cytotoxicity against Epstein-Barr virus (EBV) infected human B-
lymphocyte Raji cells (IC50 = 0.003 µg/mL).2  Tsuda et al. speculate that this toxicity may be 
due to the presence of the hemiketal embedded within a tetrahydropyran motif, as other 
highly cytotoxic marine natural products, an example being peloruside A, have also shown 
potent cytotoxicity and possess this architecture.2,5  Remarkably, iriomoteolide 1c, which 
also possesses a hemiketal embedded within a tetrahydropyran ring, has exhibited 
comparable cytotoxicity (IC50 = 0.002 µg/mL against human B lymphocyte DG-75 cells, IC50 
= 0.004 µg/mL against Epstein-Barr virus (EBV) infected human B-lymphocyte Raji cells) to 
iriomoteolide 1a, while iriomoteolide 1b is 450 times less potent (IC50 = 0.09 µg/mL) against 
human B lymphocyte DG-75 cells.3  This data seems to support Tsuda's hypothesis that the 
hemiketal motif of iriomoteolides 1a and 1c may play a significant role in the biological 
mechanism of action.  To date, there are no reports of biological studies or biosynthetic 
studies of the iriomoteolides. 
       
B. Previous Syntheses of Iriomoteolide 1a 
 Because of the interesting biological profile of iriomoteolide 1a, several groups have 
undertaken the total synthesis of 2.1.  The groups of Loh,6 Paterson,7 Zhao,8 Li,9 and Dai10 
have reported approaches to complex fragments of iriomoteolide 1a, while Horne,11 
Ghosh,12 and Yang13 have completed the total synthesis of iriomoteolide 1a (2.1).  During 
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the course of their synthetic studies, Horne, Ghosh, and Yang independently ascertained 
that the proposed structure of iriomoteolide 1a had been misassigned.11-13 Their various 
approaches to the proposed structure and conclusions about the identity of the natural 
product are discussed in the proceeding sections.   
 
1.1 Horne's Approach to Iriomoteolide 1a 
 Horne's retrosynthetic plan for iriomoteolide 1a is depicted in Scheme 2.1.  Initially, it 
was believed that iriomoteolide 1a (2.1) would arise from an esterification of secondary 
alcohol 2.5 with acid 2.6, followed by a late stage RCM to form 2.1.  Hemiketal 2.5 could be 
accessed from a β-alkyl Suzuki-Miyaura coupling of vinyl iodide 2.7 and alkyl iodide 2.8.11      
 
 Preparation of alkyl iodide 2.8 began with a Frater-Seebach alkylation of 
enantiomerically enriched (3S)-methyl hydroxybutyrate (2.9), containing the correct 
orientation of the C22 hydroxyl, to provide allylated product 2.10 in 92% yield (Scheme 
2.2).14  In six steps, involving protection of the secondary alcohol at C22, reduction of the 
ester to an alkane, and cleavage of the terminal olefin using ozonoloysis, aldehyde 2.11 was 
formed which underwent a Masamune anti aldol with norphedrine based chiral auxiliary 2.12 
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to generate aldol adduct 2.13 containing the stereocenters at C18 and C19 in 92% yield, 
and as a single diastereomer.  In four additional steps, the resultant C19 hydroxyl was 
protected, the chiral auxiliary was cleaved under standard reduction conditions, and the 
resultant primary alcohol was transformed into alkyl iodide 2.8 in 65% yield over 4 steps and 











 Construction of vinyl iodide 2.7 commenced with a Sharpess asymmetric 
dihydroxylation of olefin 2.14 to furnish tertiary alcohol 2.15, which is the tertiary alcohol at 
C14 present in the natural product (Scheme 2.3).15  Protection of the resultant diol as PMP 
acetal 2.16, cleavage of the PMBz protecting group, followed by oxidation of the resultant 
primary alcohol provided aldehyde 2.17.14  In a three step sequence beginning with an 
Ohira-Bestmann reaction to produce alkyne 2.18, followed by hydrohalogenation by 
sequential treatment with tributyl tin hydride in the presence of Pd(PPh3)4 and then 
iodination, E-vinyl iodide 2.19 was furnished.  Deprotection of the PMP acetal under acidic 
conditions and protection of the resultant diol as the bis TES ether delivered 2.20, which 
underwent a selective primary TES ether deprotection in the presence of catalytic PPTS and 

























































2.21. Subseqent use of 2.21 in a Sakuri reaction with allyl silane 2.22,15 allowed for the C12-
C13 carbon-carbon bond to be forged.  Protection of the resultant secondary alcohol as the 











































PMP 1. Bu3SnH, Pd(PPh3)4
2. I2









I81% for 2 steps
1. PPTS (cat), MeOH
2. DMP















 With the two necessary fragments in hand, exposure of alkyl iodide 2.8 and vinyl 
iodide 2.7 to Suzuki reaction conditions smoothly coupled the two fragments to form the 
C16-C17 bond in 82% yield (Scheme 2.4).  The acetate of 2.23 was then cleaved using 
LiAlH4 with concomitant loss of the tertiary TES ether, while the secondary TES ether 
remained intact.14  Oxidation of the C13 hydroxyl delivered ketone 2.24; subseqent exposure 
to mild ketalization conditions to prevent migration of the C11 olefin into conjugation, 
furnished hemiketal 2.5.14 
 Attempts to complete the synthesis of the proposed structure hinged upon a 
successful Yamaguchi esterification of hemiketal 2.5 and acid 2.6.  However, due to the 
instability of the hemiketal unit, a 50-60% yield of ester 2.25 was obtained utilizing 
Yamaguchi esterifcation conditions, and subsequent chromatographic separation of 2.25 









































63% for 2 steps 70%














 Horne instead took an alternative approach to iriomoteolide 1a which would install 
the sensitive hemiketal functionality at the end of the synthesis.  A few protecting group 
modifications were necessary in order to execute this strategy: the C9 TES ether was 
replaced as a PMB ether, while the C13 acetate was changed to a TBS ether to form new 
vinyl iodide 2.26 (Scheme 2.6).  
 To complete the synthesis, vinyl iodide fragment 2.26 was coupled under Suzuki 
conditions with alkyl iodide 2.8 to furnish the coupled product 2.27 (Scheme 2.6).11 Selective 
deprotection of the TES ether of C19 followed by Yamaguchi esterification with acid 2.6 
afforded 2.28 in higher yields (84% for 2 steps) compared to attempts with the hemiketal 
moiety already installed (Scheme 2.5).  Deprotection of the silyl protecting groups and 
oxidation of the resultant diol delivered ketone 2.29 which was exposed to DDQ to effect 
global deprotection of the PMB groups with concomitant hemiketal formation.  Formation of 
the macrocycle with Grubbs' 2nd generation catalyst gave the proposed structure of 
iriomoteolide 1a (2.1) in 49% yield over 2 steps and in 23 steps as the longest linear 







































 Comparison between synthetic iriomoteolide 1a and what was reported in the 
literature for the natural material revealed that the natural product was misassigned.  Horne 
notes that the main discrepancies between the two spectra reside with the proton and 
carbon chemical shifts at C4, as synthetic iriomoteolide 1a C4 proton appears at 3.95 ppm 
and the carbon shift for C4 occurs at 41.0 ppm, compared to the natural compound which 
occurs at 2.46 ppm and 47.9 ppm for proton and carbon, respectively.  Horne speculates 
that the discrepancies between the natural product and synthetic iriomoteolide 1a may 
reside in the C2-C3 olefin geometry, suggesting that the C2-C3 olefin is actually an E olefin 




























































































1.2 Ghosh's total synthesis of the proposed structu re of iriomoteolide 1a 
 Ghosh concurrently published a synthesis of the proposed structure of iriomoteolide 
1a in 2010.  His approach, depicted in Scheme 2.7, relied on the convergency of two 
aldehyde 2.30 and sulfone 2.31 through a Julia- Kocienski olefination.12       
   
 Construction of aldehyde 2.30 began with an enzymatic kinetic resolution of Weinreb 
amide 2.32 to deliver enantiomerically enriched β-hydroxy amide 2.33 in 45% yield and 97% 
ee, containing the C9 stereocenter (Scheme 2.8).  In nine steps, 2.33 was converted to allyl 
silane 2.34 in 13.8% overall yield.  Allyl silane 2.34 underwent a chelation controlled Sakurai 
addition with aldehyde 2.35, prepared in four steps from 2- methylene-1,3-propanediol to 
deliver a diol as a 8:1 mixture of diastereomers at C13 which was then protected to provide 
acetonide 2.36.  Oxidation of the sulfide to the sulfone, and a Julia Kocienski olefination with 
aldehyde 2.37, prepared in 15 steps from commercially available tert-butyl acetate, 





 Sulfone 2.31 was prepared from enantiomerically enriched alcohol 2.38, prepared via 
a Brown crotylboration of acetaldehyde (Scheme 2.9).  In three steps, alcohol 2.38 was 
elaborated into aldehyde 2.39 which underwent a second Brown crotylboration utilizing (−)-
β-methoxydiisopinocamphenylborane and trans-2-butene to deliver the anti alcohol 2.40 as 
a 10:1 mixture of diastereomers.  Construction of sulfone 2.31 was completed after four 
additional manipulations, involving protection of the C19 hydroxyl group as the PMB ether, 
hydroboration of the olefin, and formation of the sulfone.12   
 To complete the synthesis, a Julia-Kocienski olefination was used to unite sulfone 
2.31 and aldehyde 2.30 to provide olefin 2.41 in 70% yield.  In ten steps, involving changes 
in oxidation state and protecting group modifications, the macrocycle is eventually closed 
utilizing a Yamaguchi macrolactonization to furnish 2.42. Global deprotection of 2.42 
followed by concomitant hemiketal formation was realized with HF.pyr to deliver the 
proposed structure of iriomoteolide 1a (2.1) in 56% yield and 17% of the proposed structure 






































































 Ghosh also notes the discrepancies in the NMR data present between the proposed 
structure of iriomotoelide 1a and what was reported for the natural substance by publishing 
a histogram of differences in carbon shifts between the two spectra (Figure 2.2).  Ghosh 
suggests, as Horne also suggested, that the enoate olefin geometry is E and not Z as 
indicated in the isolation paper, based on C24 chemical shift (1.96 and 20.8 ppm for 
synthetic 2.1 compared to 2.12 and 23.8 for natural 2.1).  In addition, Ghosh suggests that 
























































































































synthetic iriomoteolide 1a could indicate that the synthesized material is an epimer at the C4 
position of the natural product.12   The spectral data for synthetic iriomoteolide 1b also did 
not match the data reported for the natural material in the original isolation paper.  
 
    
1.3 Yang's Approach to Iriomoteolide 1a 
 Yang and coworkers amended their strategy to the natural product to account for the 
discrepancy in enoate geometry, which they determined to be incorrectly assigned during 
the course of their synthetic studies, and hence targeted the proposed structure with the E 
enoate geometry (2.43, Scheme 2.10).13 The primary reason they speculated that the 
enoate geometry was misassigned was with regards to the chemical shift at C24, which was 
thought to be too far downfield to be a Z-enoate (2.12 ppm and 23.8 ppm for proton and 
carbon, respectively), and was consistent with an E-enoate.13,17  Additionally, Yang 
speculated that the ROESY correlation between C24-Me and C2-H was just a remnant of a 
COSY correlation which are also present in ROESY spectra, and should be disregarded 
(Figure 2.1).13  Yang's retrosynthetic plan is highlighted in scheme 2.10.  The hemiketal of 
(E)-iriomoteolide 1a (2.43) would be formed from an intramolecular reductive cyclization of 
iodide 2.44.13  The macrocyle would be installed through a ring closing metathesis across 
Figure 2.2 : Ghosh's historgram of differences in C13 chemical shift for synthetic
iriomoteolide 1a versus natural iriomoteolide 1a.12
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the C15-C16 olefin from diene 2.45.  Diene 2.45 would be prepared via a Mitsunobu with 
carboxylic acid fragment 2.46 and a base mediated alkyne chloroformate coupling between 














 Chloroformate 2.47, which embodies carbons C16-C23, was synthesized along a 
similar route as Ghosh's approach to the same fragment (Scheme 2.11).13  Aldehyde 2.39 
was prepared in four steps from acetaldehyde utilizing a Brown crotylation.  Aldehyde 2.39 
was then subjected to an iterative Brown crotylboration, and the resultant secondary 
hydroxyl group at C19 was protected to furnish PMB ether 2.49.  In three steps, PMB ether 
2.49 was homologated to olefin 2.50.  Deprotection of the PMB ether followed by reaction of 











































































Scheme 2.10 : Yang's approach to (E )-iriomoteolide 1a
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 Carboxylic acid 2.46 was synthesized according to Zhang's procedure (Scheme 
2.12).  Treatment of (S)-lactic acid (2.51) with acid and bis-dihydropyran 2.52 under Ley's 
conditions generated the "dispoke protected lactate" in a 12:1 d.r. with predominant 
diastereomer 2.53 having the methyl group occupying the equatorial position.19 An aldol 
reaction of acetaldehyde and "dispoke" 2.53 yielded secondary alcohol 2.55 as the 
predominant diastereomer, which was tosylated, eliminated, and the auxiliary cleaved under 
acidic conditions to generate carboxylic acid 2.46.18  








 To synthesize alkyne 2.48, Aldehyde 2.56, which was formed in 8 steps for β-
methallyl alcohol (2.57),20 underwent an asymmetric propargyl addition with 2.58 via 

















71% for 2 steps 75%





























major 2.53: R1 = H, R2 = Me









1. triflic anhydride, pyr
2. DBU
3. 95% TFA
68% for 3 steps
HO2C
OHMe






(Scheme 2.13).  Deprotection of the TIPS alkyne and reprotection of the secondary alcohols 
as the silyl ethers delivered alkyne fragment 2.60.  Coupling of chloroformate 2.47 and 
acetylene 2.60 was accomplished under basic conditions to form an alkynoic ester, which 
was subjected to a cuprate addition employing TMSCl and the Gillman reagent to provide 
the desired E-enoate in 98% yield and a 1:10 Z/E ratio.  At this point, oxidative cleavage of 
the PMB ether, followed by a Mitsunobu reaction with acid 2.46 formed trienyne 2.61, which 
underwent smooth ring closing metathesis in the presence of Grubbs' 2nd generation catalyst 
to form 2.62.  Remarkably, 2.62 was obtained in 62% yield, with the E isomer being formed 
exclusively.  In five steps, the primary TBS was transformed into iodide 2.44, which was 
exposed to reductive cyclization conditions employing SmI2 followed by global deprotection 
of the silyl ethers to give (E)-iriomoteolide 1a (2.43) in 53% yield over 2 steps and 22 steps 
as the longest linear sequence.13 
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 Comparison of the spectroscopic data for (E)-iriomoteolide 1a (2.43) to the natural 
product revealed that the synthesized structure is likely a diasteromer of the natural product, 
with one or more stereocenters being misassigned.  Yang points out that the configurational 
analysis (analyzed by J couplings) for the C4-C5 and C21-C22 stereocenters in the original 
isolation paper is questionable, as the H23, H25, and H29 each belong to a conformationally 
unbiased methyl group, and is therefore not a reliable means of garnering coupling 
constants.  This makes the assignment of all stereocenters in iriomoteolide 1a questionable, 



























































































 Yang also synthesized two additional diastereomers (2.63 and 2.64, Figure 2.3) 
along the same synthetic sequence, in which stereocenters at C9, C14, C18, C19, and C21 
differ from the proposed structure.  These structures also did not match the data reported for 
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Synthetic Studies Directed Toward the Total Synthes is of Iriomoteolide 1A  
 A.  Retrosynthesis of iriomoteolide 1a 
 The major bond disconnections for iriomoteolide 1a are highlighted in scheme 3.1.  It 
was envisioned that iriomoteolide 1a (2.1) would arise through a highly convergent approach 
in which the 20-membered macrolide would be installed via a late stage Yamaguchi 
macrolactonization of seco-acid 3.1.  Acid catalyzed deprotection of the triethylsilyl ether 
protecting group at C9 with concomitant cyclization of ketone 3.2 would afford mixed methyl 
ketal 3.1.  Ketone 3.2 was envisaged to result from a nonselective aldol reaction of ketone 
3.3 and aldehyde 3.4.  It was thought that ketone 3.3 could be prepared via a cross 
metathesis of secondary alcohol 3.5 and tertiary alcohol 3.6, and aldehyde 3.4 would also 






B.  Preparation of the C16-C23 fragment of iriomote olide 1a 
 Initial efforts toward the total synthesis of iriomoteolide 1a focused on the preparation 
of secondary alcohol 3.5 (Figure 3.1) utilizing the thiazolidinethione technology developed in 
the Crimmins laboratory to install all four 
stereocenters.1-2  The stereocenters at C21 and 
C22 could be installed by performing an Evans syn 
aldol addition with (R)-benzyl thiazolidinethione 3.9 and acetaldehyde to deliver aldol adduct 
3.10 in 87% yield and >20:1 d.r. (Scheme 3.2, A),1,2 or alternatively a non-Evans syn aldol 
addition with (S)-benzyl thiazolidinethione 3.11 and acetaldehyde, which generated aldol 







Figure 3.1 : C16-C23 fragment of iriomoteolide 1a.
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sparteine, the aldol addition which utilized Evans syn conditions to form aldol adduct 3.10 
was explored utilizing a different base to effect enolization.  In the absence of (−)-sparteine 
as a base, the aldol adduct could be formed utilizing i-Pr2NEt as a base; however, an 
additional equivalent of NMP (2 equiv. total) was necessary to obtain consistently high levels 
of diastereoselectivity.3 This generated the aldol adduct in slightly lower yields (80% yield) 
compared to the 87% yield obtained when (−)-sparteine was employed as a base, and is 
consistent with results obtained by former group member Jin She.3   
 








 At this juncture, protection of secondary alcohol 3.10 or 3.12 as the tert butyl 
dimethyl silyl (TBS) ether occurred in the presence of TBSOTf and 2,6-lutidine to afford TBS 
ethers 3.13 and 3.14 in high yield (Scheme 3.2).  The auxiliaries were then reductively 
cleaved to deliver alcohol 3.15 (Scheme 3.3).  Attempts to perform a one carbon 
homologation of 3.15 utilizing DIAD, PPh3, and acetone cyanohydrin to produce nitrile 3.16 

























































base = (-)-sparteine, 87% yield
base = i-Pr2NEt, 80% yield
3.9 3.10
3.11 3.12















 Employing 1.5 equiv. of DIAD, 1.5 equiv. PPh3, and 10 equiv. of acetone 
cyanohydrin at 70 °C resulted in the formation of the  product in low yields (33%).  
Furthermore, addition of an extra 1.5 equivalents of both PPh3 and DIAD after 12 h, which 
improved the yield of nitrile formation in the synthesis of (+)-SCH 351448, did little to 
improve the yield of the reaction.4  Additionally, resultant nitrile 3.16 was tainted with the 
excess DIAD used in the reaction, and difficult to purify via chromatography.  
 Therefore, a two step process was employed to form the desired nitrile (Scheme 
3.4).  Primary alcohol 3.15 was first transformed into mesylate 3.17 employing 
methanesulfonyl chloride and triethylamine in 93% yield.  Exposure of mesylate 3.17 to KCN 
and heating to 55 °C for 2 days 
provided nitrile 3.16, which upon 
immediate exposure to reducing 
conditions exploiting i-Bu2AlH afforded  














































































  At this point, a second aldol iteration utilizing Evans syn aldol conditions with (S)-
benzyl thiazolidinethione 3.19 was explored.  Utilizing (−)-sparteine as a base allowed for 
the generation of aldol adduct 3.20 in moderate yield, and high diastereoselection (>20:1) 
(Scheme 3.5).  Alternatively, Hünig's base was also effective, inducing both high 
diastereoselection and yield (Scheme 3.5). Reductive cleavage of the auxiliary with LiBH4 
revealed diol 3.21, which was subjected to tosyl chloride, DMAP, and Et3N to selectively 
form the primary tosylate 3.22.  It was thought that upon exposure of tosylate 3.22 to 
LiEt3BH, a hydride would displace the tosylate to form olefin 3.5.
6  However, upon exposure 
of 3.22 to LiEt3BH the desired product 3.5 along with oxetane 3.23 was formed in 1:3 ratio, 



































Scheme 3.5 : Synthesis of tosylate 3.22.
base = (-)-sparteine, 68% yield
base = i-Pr2NEt, 94% yield














 Paterson and coworkers also reported the formation of an oxetane utilizing LiEt3BH  
in a similar substrate toward the synthesis of (+)-discodermolide (Scheme 3.6, A), and found 
that treatment with LAH generated the desired alcohol in 97% yield (Scheme 3.6, B).7 
Subjecting tosylate 3.22 to Patterson's conditions utilizing  LAH provided only a 1:1 mixture 
of the desired product 3.5 and oxetane 3.23 in 45% yield (Table 3.1, entry 2). 
 
 Because of the propensity for the secondary alcohol at C19 to perform an 
intramolecular displacement of the C21 tosylate, the secondary alcohol was protected as the 
TES ether following aldol addition (Scheme 3.7) to deliver a TES ether.  At this point, the 
auxiliary was reductively cleaved using LiBH4 to afford primary alcohol 3.27, which was 
Entry  Hydride 
source 
Temperature  3.5:3.23 Yield  
1 LiEt3BH -78 ° C  1:3 n.d. 


































































exposed to tosyl chloride, DMAP, and triethyl amine to furnish the tosylate.  Displacement of 
the tosylate readily occurred at room temperature with LiEt3BH to generate terminal olefin 











C.  Synthesis of the C12-C15 fragment 
  It was envisaged that the C12 - C15 
fragment (3.6) could be accessed in short order 
from commercially available (S)-ethyl lactate (3.29) 
(Scheme 3.8).  Following a literature procedure,8 
(S)-ethyl lactate (3.29) was exposed to PMB-acetimidate9 and triflic acid to generate PMB 
ether 3.30 in 62% yield (Scheme 3.9).  Transformation of the ester into the Weinreb amide 
was accomplished using i-PrMgCl and N,O-dimethylhydroxylamine hydrochloride to furnish 
amide 3.31 in 76% yield.8  Vinyl Grignard addition then provided enone 3.32 in 95% yield.  
Resultant enone 3.32 was subjected to a chelation controlled addition using methyl 
magnesium bromide to deliver the desired tertiary alcohol 3.33 in reasonable yield and 20:1 
d.r.  Exposure of 3.33 to oxidative deprotection conditions utilizing DDQ resulted in the 
















































While not an ideal cleavage of a protecting group by any means, it was believed that the 
resultant ester could be cleaved under basic or reducing conditions to reveal diol 3.35.  
Treatment of the ester with K2CO3 and MeOH led to cleavage of the ester and formation of 
diol 3.35, but unfortunatly, diol 3.35 proved to be quite difficult to work with, as it was 
complicated to isolate from the aqueous layer due to its hydrophilicity, and readily 













 Because diol 3.35 proved difficult to isolate, we decided to explore the key cross 
metathesis between C16-23 fragment (olefin 3.5 or 3.28) and the C12-C15 fragment before 
cleavage of the PMB ether, as it was reasoned that formation of a diol with more nonpolar 
substituents may be easier to isolate. 
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62%
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 To this end, a cross metathesis was attempted with tertiary alcohol 3.33 and 
secondary alcohol 3.5 (Scheme 3.10).  Utilizing Hoveyda-Grubbs 2nd generation catalyst,10 3 
equiv. of 3.33 and 1 equiv. of 3.5, the crossed product 3.36 was isolated in an unremarkable 
30% yield.  It was thought that better matching of the coupling partners based on olefin 
reactivity in the cross metathesis would result in higher yields.11 
 
  Therefore, a cross metathesis between enone 3.32 and terminal olefin 3.28 was 
investigated (Scheme 3.11).  Utilizing Hoveyda-Grubbs' second generation catalyst, 2 
equivalents of enone 3.32 and 1 equivalents of terminal olefin 3.28 allowed for enone 3.37 
to be isolated in 86% yield.  At this point, a chelation controlled addition with methyl 
Grignard afforded tertiary alcohol 3.38 in high diastereoselectivity (20:1).  At this stage, it 
was thought that deprotection of the PMB ether with two equivalents of DDQ would form an 
ester, as it had in earlier work (Scheme 3.9).  In this case, formation of the ester did occur; 
however, treatment with DDQ also resulted in concomitant loss of the TES protecting group 






















 Due to this circumstance, different protecting groups were explored for the hydroxyl 
group at C13.  It is known that DMB protecting groups cleave more readily in the presence 
of DDQ than a PMB, and thus be less likely to cleave a TES group due to prolonged 
exposure to DDQ.12  To this end, the secondary alcohol of (S)-ethyl lactate (3.29) was 
protected to afford DMB ether 3.40, transformed into Weinreb amide 3.41, and vinyl 
Grignard addition was used to provide enone 3.42 along the previously developed synthetic 




























CH2Cl2/ pH 7 buffer
1:1






























 Cross metathesis of TES ether 3.28 with enone 3.42 generated the crossed product 
3.43 in 71% yield as exclusively the E isomer.  Chelation controlled methyl Grignard addition 
of 3.43 furnished tertiary alcohol 3.44 in 79% yield.  However, upon exposure of 3.44 to 
DDQ, ester 3.45 was formed along with concomitant loss of the TES ether protecting group. 
Though there are examples of secondary TES ethers remaining intact in the presence of 
DDQ,13 TES ethers 3.46 are also known to undergo oxidative cleavage in the presence of 





 Ultimately, the secondary alcohol of (S)-ethyl lactate (3.29) was protected as the 























































CH2Cl2/ pH 7 buffer
1:1



























hydrochloride and i-PrMgCl delivered Weinreb amide 3.49, which was subjected to a vinyl 
Grignard addition to furnish enone 3.50. Cross metathesis with enone 3.50 and terminal 
olefin 3.28 generated enone 3.51, which was exposed to methyl Grignard to deliver tertiary 
alcohol 3.52 in 20:1 d.r and 91% yield.  Deprotection under reductive conditions employing 
LiDBB15 proceeded smoothly to deliver a diol, which was oxidized under Parikh-Doering 














E. Synthesis of the C1-C11 fragment 
 Synthesis of the C1-C11 fragment (Figure 
3.2) commenced by performing an Evans anti aldol 
reaction between thioimide 3.11 and cinnamaldehyde to arrive at TMS protected aldol 
adduct 3.54 (Scheme 3.15).17  Deprotection of the quite labile TMS group under acidic 
conditions, and replacement with a TBS group, generated TBS ether 3.56 in 87% yield over 
















































































Scheme 3.14 : Completion of the C12-C23 f ragment of iriomoteolide 1a.
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furnish aldehyde 3.57, which was subjected to a two step Corey-Fuchs homologation18 to 
arrive at ynoate 3.59.  A conjugate methyl addition to ynoate 3.59 utilizing the Gillman 
reagent19 provided the Z-enoate 3.8, as confirmed by observed NOESY interactions.   
 
 
 Preparation of the aldehyde fragment was straightforward, as it involved an acetate 
aldol addition between mesityl substituted thiazolidinethione 3.6020 and 3-butenal21 
generating aldol adduct 3.61 in 70% yield and 20:1 d.r (Scheme 3.16).  Exposure of the 
resultant alcohol to silylation conditions provided TES ether 3.62, and cleavage of the chiral 
auxiliary employing i-Bu2AlH furnished aldehyde 3.7 to be used in the key cross metathesis.  
Alternatively, the same fragment could be accessed along the same synthetic sequence; 
however, instead of utilizing mesityl thiazoldinethione 3.60, (S)-1-(4-benzyl-2-
thioxothiazolidin-3-yl)ethanone (3.63) was employed in an aldol with 3-butenal to afford the 












1.1 Cross metathesis attempts with aldehyde 3.7 and  ester 3.8 
 A cross metathesis between 3.7 and 3.8 utilizing 10 mol% Grubbs' 2nd generation 
catalyst in refluxing CH2Cl2 was expected to deliver the C1-C11 fragment (3.4, Scheme 
3.17).  However, it was found that under these conditions, the only product obtained was 
homodimerized aldehyde 3.66 along with unreacted 3.8.  It was reasoned that the bulky 








 An alternative approach utilizing ynoate 3.59 was also investigated (Scheme 3.18).  
Because the TBS ether was likely causing the internal olefin to be too hindered to undergo a 
cross metathesis, the TBS ether was cleaved under acidic conditions to reveal allylic alcohol 














































3.61 R=Mes, 70%, 20:1 d.r.
3.64 R=Bn, 41% desired, 1.3:1 d.r








provide any of the desired alkynoate 3.68, but instead provided exclusive formation of the 
aldehyde dimer (3.66).   
    
 
1.2. Relay cross metathesis strategy to access the C1-C11 fragment 
 At this stage, an unconventional cross metathesis strategy was examined.  In the 
context of substrates containing two 1,1 disubstituted ethylene moieties (3.69), ring closing 
metathesis has proven to be a difficult task utilizing Grubbs' 1st generation catalyst, as the 
olefinic sites are quite sterically hindered 
(Scheme 3.19, A).22a  Though 2nd and 3rd 
generation catalysts have been developed 
to overcome this challenge, forming 
tetrasubstituted olefins remains a daunting 
task.23  One strategy to overcome this 
shortcoming came with the advent of relay 
RCM.22  In this approach (Scheme 3.19, B), 
a temporary tether containing an 
unhindered terminal olefin (3.71) is 
introduced such that a kinetically favorable five membered ring is formed as a byproduct 
(3.73) while delivering the ruthenium catalyst onto the sterically encumbered internal 
position (3.74).  Once the Ru is delivered onto the sterically hindered olefin, it can undergo a 






























   
  
 We believed that we could employ a relay strategy in the total synthesis of 
iriomoteolide 1a, specifically using this strategy to create the C6-C7 E olefin.  In the 
proposed reaction, the Ru complex would first insert into the unhindered terminal olefin 
(3.75, Scheme 3.20), providing Ru-carbene 3.76.  Ru carbene 3.76 would undergo a 
kinetically favorable ring closing metathesis forming indene (3.77) as a byproduct, while 
delivering the Ru catalyst to the hindered internal olefin, to furnish 3.78.  Once the Ru 
carbene was on the sterically hindered position, 3.78 would undergo a cross metathesis with 
aldehyde 3.7 to generate the C1-C11 fragment (3.4).   
 
 
1.2.1. Preparation of the Relay Partner 3.75 






















THF, -78 °C to -20 °C 2:1 dioxane: water, 80 °C
81% for 2 steps
H
H




































Deprotection of acetal 3.80 under acidic conditions afforded aldehyde 3.81, which was 
exposed to ylide 3.82 to furnish enal 3.83.  Unfortunately, resultant enal 3.83 was isolated in 
a low 28% yield, as a 1:1 mixture of E and Z isomers.  
 A more straightforward, albeit lengthier, alternative approach proved to be a useful 
strategy to access enal 3.83 (Scheme 3.22).  A Horner-Wadsworth Emmons olefination with 
phosphonate 3.84 and aldehyde 3.81 formed ester 3.85 in 87% yield as a 10:1 mixture of 
E/Z isomers.  Reduction of ester 3.85 to the alcohol was accomplished utilizing i-Bu2AlH, 
followed by allylic oxidation with MnO2 delivered enal 3.83 in 80% yield for two steps.  An 
Evans anti aldol with enal 3.83 and thioimide 3.11, followed by an acidic workup, generated 
aldol adduct 3.86 in 76% yield.  Protection of the secondary alcohol as the TBS ether and 
reductive removal of the chiral auxiliary afforded aldehyde 3.87.  In two steps, involving a 
Corey-Fuchs homologation and addition of the Gillman reagent, enoate 3.75 was formed in 




1.2.2 Cross metathesis attempts with relay substrat e 3.75  
 Exposure of the resultant relay substrate 3.75 to Grubbs' 2nd generation catalyst 
was expected to lead to the truncated terminal olefin 3.89 (Scheme 3.23, A).  Unforturnatly, 
under cross metathesis conditions, a complex mixture was obtained, with no desired olefin 
3.89 detected.  Furthermore, exposure of the relay substrate to Grubbs' 2nd generation 
catalyst with aldehyde 
3.7 did not lead to any 
of the desired C1-C11 
fragment (3.4, B, 








































80% for 2 steps
1. 2,6-lutidine, TBSOTf
CH2Cl2, 0 °C to rt


























































1.3 Other potential stratagies to access the C1-C11  fragment 
 Because the internal olefin was likely too hindered to undergo a relay ring closing-
cross metathesis, we next explored replacing the cinnamyl group of the C1-C6 fragment with 
a terminal olefin.  Though there appears to be a straightforward solution to access terminal 
olefin 3.89, in simply replacing cinnamaldehyde with acrolein in the Evans anti aldol, 
acrolein has not been shown to be a suitable substrate for the Evans anti aldol.17a  Several 
potential strategies were considered as a means to access a terminal olefin substrate.  Use 
of Urpi's acetal aldol25 in conjunction with acrolein dibenzyl acetal, would generate the 
desired stereochemistry and a terminal olefin; however, this sequence would add an 
additional deprotection step later in the synthesis of the natural product (Scheme 3.24, A).  
Alternatively, an acetate aldol with 
acrolein could provide β-hydroxy 
amide, which could subsequently be 
utilized in a Frater-Seebach alkylation26 
to form the C4 stereocenter (Scheme 
3.24, B).  This option would add at 
least three steps to the synthetic 
sequence.  An ozonolysis/methylene 
Wittig sequence was also considered, 
but this could a problematic strategy if 
other olefins or aldehydes were 
present in the substrate undergoing 
ozonolysis/methylenation (Scheme 
3.24, C).  Another strategy which provided a "direct" approach to a terminal olefin from a 
cinnamyl substrate was a cross metathesis of one of the substrates along the developed 






















































Scheme 3.24: Potential strategies to access the C1-C6 fragment






1.4 Attempts to form the C6 terminal olefin utilizin g ethylene cross metathesis 
    From our earlier experience with attempted cross metatheses, it was known not to 
perform the cross metathesis with ethylene at a juncture when the TBS ether at C5 was 
installed, as the resultant internal olefin would be inaccessible to the olefin metathesis 
catalyst due to steric hindrance.  Instead, a cross metathesis was attempted with TMS 
protected aldol adduct 3.54, ethylene, and Grubbs 2nd generation catalyst (Scheme 3.25).  It 
was reasoned that the smaller TMS group may allow for the catalyst to insert into the 
internal olefin of 3.54 and undergo a cross metathesis with ethylene, to generate terminal 







 Instead, the TMS protecting group of 3.54 was removed under acidic conditions to 
reveal allylic alcohol 3.55 (Scheme 3.26).  Upon exposure of 3.55 to Hoveyda-Grubbs 2nd 
generation catalyst, under an ethylene atmosphere at a concentration of 0.01 M in CH2Cl2, 
in a sealed tube, 3.91 was obtained in 84% yield as a 20:1 mixture of terminal olefin 3.91 to 
cinnamyl starting material 3.55.  Notably, the reaction temperature and volume of ethylene 
in the sealed tube had dramatic effects on the reaction.  Heating the reaction above room 
temperature caused decomposition of the starting material.  Critical for the success of the 
reaction was the volume of ethylene relative to the volume of solvent in the sealed tube, as 
a higher ratio of starting material to product was detected when the volume of methylene 
















Scheme 3.25 : An attempt to install a terminal olefin from





          
 
1.5 Cross metatheis attempts with terminal olefin 3 .89 and aldehyde 3.7   
 With terminal olefin 3.91 in hand, the secondary alcohol was protected as the TBS 
ether, and the auxiliary was reductively cleaved with i-Bu2AlH to deliver aldehyde 3.92 
(Scheme 3.27).  Corey-Fuchs homologation provided ynoate 3.93 was followed by treatment 
with the Gillman reagent to furnish Z-enoate 3.89, as confirmed by NOESY analysis.   
 
 
Subjecting terminal olefin 3.89 to a cross metathesis with aldehyde 3.7 did not generate the 
desired C1-C11 fragment 3.4, but once again produced the dimer of aldehyde 3.7 as the 
sole product.  It was speculated that syringe pump addition of aldehyde 3.7 may allow for 










CH2Cl2, 0 °C to rt









THF, -78 °C to rt
























Scheme 3.27 : Generation of enoate 3.89 and cross metathesis attemps with aldehyde 3.7
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dimerization and allow for the desired cross metathesis to occur.  Unfortunately, 3.4 was not 
obtained when syringe pump addition was employed.  Considering the precedent by Grubbs 
et. al.,11 it seems logical that the Ru catalyst should be able to insert into olefin 3.89, and 
undergo further cross metathesis.  However, we and others27 have found this transformation 
to be difficult, likely due to the steric effects imposed by the bulky silyl ether protecting 
groups.       
 
1.6 Cross metathesis attempts with dibromide 3.95  
 Because the TBS group was posing a significant hurdle in our ultimate goal of 
synthesizing the C1-C11 fragment, it was believed that a cross metathesis of bis-silyl ether 
3.94 and dibromide 3.95 and could potentially allow for the C6-C7 bond to be forged 
(Scheme 3.28).  A selective deprotection of the primary silyl ether in the presence of a 
secondary silyl ether utilizing Swern conditions28 could then furnish aldehyde 3.4.  
 
 
   
 
 To prepare dibromide 3.95, aldol adduct 3.54 was reductively cleaved with i-
Bu2AlH to furnish aldehyde 3.96 (Scheme 3.29).
17b  Treatment of 3.96 with CBr4 and PPh3 
resulted in deprotection of the TMS ether, and formation of an unidentified product.  
However, by employing 10 equiv. of triethylamine, TMS dibromide 3.97 was isolated in 40% 
yield over two steps + 11% of the deprotected alcohol substrate.  Deprotection of the TMS 
group under acidic conditions provided allyl alcohol 3.98, which was subjected to an 
ethylene cross metathesis with Grubbs 2nd generation catalyst to afford allylic alcohol 3.95.  



















from olefin isomerization to the enol and tautomerization, was sometimes seen as a 
byproduct.  Attempts to limit the formation of bromoketone 3.99 by using 1,4-benzoquinone 
as an additive29 did not improve the overall yield of the reaction.  
 







 Efforts to perform a cross metathesis of 3.95 with bis silylether 3.94 resulted in 
disappointing yields of 3.100 when 1 equiv. of bis silyl ether 3.94 and 1 equiv. of allylic 
alcohol 3.95 were employed (Table 3.2, entry 1).  Dimerization of the dibromide 3.95 and bis 
silyl ether 3.94 were the primary byproducts of the reaction (3.101 and 3.102, respectively).  
The best results were obtained when 1.0 equivalent of allylic alcohol 3.95 and 3.4 
equivalents of bis silyl ether 3.94 were used in the reaction generating allylic alcohol 3.100 



























































Entry  Equiv. 3.95  Equiv. 3.94  Yield  
1 1.0 1.0 23% 
2 1.0 1.3 39% 
3 1.0 2.0 40% 
4 1.0 3.4 60% 
 
1.7 Attempts to complete the C1-C11 fragment   
 With 3.100 in hand, the secondary alcohol was protected as the TBS ether, and the 
dibromide transformed under basic conditions to afford ynoate 3.103 in 70% yield over 2 
steps (Scheme 3.30).  Following cuprate addition, bis TES ether 3.104 was exposed to 
Swern oxidation conditions28 in hopes that a one-pot selective deprotection of the primary 
TES silyl ether would occur followed by oxidation to yield aldehyde 3.4.  However, low yields 
(38%) and significant decomposition were obtained under the reaction conditions.  Attempts 
to improve the yield by distilling the oxalyl chloride prior to use did little to improve the 












































 A selective deprotection of the primary TES ether 3.104 was investigated (Table 3.3).   
Utilizing PPTS in 10:1 DCM/MeOH at -20 °C resulted in cleavage of both the primary and 
secondary TES groups (Table 3.3, entry 1).  Use of a more hindered alcohol, i-PrOH, 
resulted in the formation of mixtures of products (Table 3.3, entry 2).  Selective deprotection 
of the primary TES did occur with 1.3:0.1:0.3 THF/H2O/AcOH; unfortunately, the highest 
















CH2Cl2, 0 °C to rt
85%













































F. Second Generation approach to iriomoteolide 1a 
 Because the cross metathesis between bis silyl ether 3.94 and dibromide 3.95 
required in excess of 3.0 equivalents of bis silyl ether 3.94 to produce 3.100 in a reasonable 
yield, and because the selective deprotection of primary TES ether 3.104 was problematic, 
we decided to reassess our original strategy to access iriomoteolide 1a.  Instead of 
performing a cross metathesis to form the C6-C7 E olefin, a ring closing metathesis would 
be used to install the macrocycle of iriomoteolide 1a while forging the C6-C7 E olefin.  Horne 
also utilizes a ring closing metathesis in his synthesis or iriomoteolide 1a.30  This strategy 
would require a few protecting group changes, as well as some changes in the order of 
steps (Scheme 3.31).  It was envisioned that iriomoteolide 1a could arise from an 
unselective aldol reaction of aldehyde 3.7 and ketone 3.106 to produce 3.107.  Then acid 
catalyzed deprotection of the C9 TES ether of 3.107 followed by concomitant ketalization 
would deliver mixed methyl ketal 3.108.  Oxidation and methylenation of C11 alcohol would 
Entry  Condition s Temperature 
(°C) 
Result  






cleavage of primary 
and secondary 


























Table 3.3: Attempts to selectively deprotect the primary TES ether of 3.104 to afford 3.105.
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install the exocyclic olefin of 3.109.  Deprotection of the C19 protecting group would form the 
free hydroxyl at C19, which could undergo a Yamaguchi esterification with acid 3.110 to 
provide ester 3.111.  Global deprotection and a ring closing metathesis would furnish 
iriomoteolide 1a. 
 
 For this new synthetic strategy toward iriomoteolide 1a to be executed, a protecting 
group differentiation between the C19 and C9 hydroxyl group was necessary.  It was 
believed that the C9 could remain protected as a TES ether, while the C19 could be 
changed from a TES ether to a PMB ether. 
 
1.1  Protection of  the C19 hydroxyl group as the P MB ether  
 Initial attempts to protect the C19 hydroxyl as the PMB ether centered on selective 
functionalization of the primary alcohol of 3.21 as the mesylate, followed by use of PMB 
acetimidate 3.113 to protect the secondary alcohol of 3.112.  Selective mesylation of the 
76 
 
primary alcohol was accomplished utilizing 2,4,6-collidine and methanesulfonyl chloride to 
generate the mesylate 3.112  in 65% yield (Scheme 3.32).31 
 
 
   
 
 
 Attempts to protect the C19 hydroxyl of 3.112 utilizing PMB-acetimidate 3.113 
resulted in decomposition under all conditions screened, and no detection of the product by 












 Ultimately, the C19 hydroxyl was protected as the PMB ether following a two step 
sequence: initial formation of the PMP acetal of diol 3.21, followed by i-Bu2AlH assisted 
regioselective opening of the PMP acetal to form the PMB ether (Scheme 3.33).32  Primary 
alcohol 3.115 was then transformed into mesylate 3.114 which was displaced utilizing 
LiEt3BH to provide terminal olefin 3.116.  Cross metathesis with enone 3.50 occurred as it 
Acid catalyst  Solvent  Temperature  
(°C) 
Result  
BF3OEt2 CH2Cl2 0 Decomposition 
BF3OEt2 CH2Cl2 -78 Decomposition 
p-TsOH CH2Cl2 25 Deprotection of TBS group 
































had in similar substrates providing 3.117 in high yield, which underwent a chelation 
controlled methyl Grignard addition and deprotection of the benzyl ether to afford diol 3.118. 


















1.2 Efforts directed toward the installation of the  exocyclic methylene at C11 
 With ketone 3.106 in hand, an nonselective aldol reaction employing LDA was 
utilized to forge the C11-C12 bond, generating the secondary alcohol products 3.107 in 60% 
yield as a 1:1 mixture of inseparable diastereomers, also containing some of the migrated 
TES ether substrate 3.119 (Scheme 3.34).  Ketalization using 10 mol% PPTS in MeOH with 











































































could be separated by column chromatography.  Oxidation of the secondary alcohol of 
3.108 to ketone 3.120 only occurred readily with one of the alcoholic substrates under 
Parikh-Doering conditions.  Notably, the other alcoholic substrate, the stereochemistry of 
which was not identified, as the stereocenter was inconsequential, and was erased in the 
oxidation step, did not undergo oxidation utilizing Parikh-Doering oxidation conditions, but 
use of the Swern protocol provided ketone in 70% yield. 
 
 
 With 3.120 in hand, a methylenation to install the exocyclic olefin was explored.  
Initial treatment of 3.120 with the Wittig reagent did not provide exocyclic olefin 3.109, but 
resulted in elimination of the OMe group (Table 3.5, entry 1).  This result was attributed to 







































3.107: R1 = TES, R2 = H




















of potassium tert-butoxide.  Careful drying of the phosphonium salt prior to ylide formation, 
using an excess amount of the phosphonium salt relative to potassium tert-butoxide, or the 
use of a salt-free ylide were anticipated to lead to generation of desired exocyclic olefin 
3.109.  However, this was not the case, as loss of the OMe group was experienced in every 
attempt which utilized a Wittig olefination.  Other olefinations (Tebbe,33 Tour,34 and Takai-
Nozaki35) were also explored, but these resulted in decomposition of the starting material 












It was believed that the unprotected tertiary alcohol at C14 could be the source of problems 
in the Wittig olefination, as it was likely that the ylide was deprotonating the tertiary alcohol, 
and then either an intermolecular or intramolecular elimination was leading to the loss of the 
OMe group. Due to these circumstances, it was thought that protection of the C14 tertiary 
alcohol may lead to increased reactivity of the C11 ketone.  Attempts to protect tertiary 
alcohol of 3.120 as either the TES or TMS ether utilizing TMSOTf or TESOTf and Hünig's 
base led cleanly to the formation of mixed silyl ketal 3.121 (R = TMS) or 3.122 (R = TES) 
(Scheme 3.35).  In similar systems, the use of a smaller silyl group that is less Lewis acidic 
Entry  Reagent  Temperature  Result  
1 Wittig 0 °C β-elimination 
 
2 Tebbe -40 °C to rt Decomposition 
 




0 °C Decomposition  
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has been shown to favor protection of the alcohol over mixed silyl ketal formation.36  
Attempts to protect tertiary alcohol 3.123 of a model system with TMSCl led to a 1:1 mixture 
which appeared to be mixed silyl ketal 3.124 and TMS protected tertiary alcohol 3.125.   
  
1.3 Attempts to protect the C14 tertiary alcohol as  the triethylsilyl ether 
 Several strategies were attempted to protect the tertiary alcohol as the silyl ether at 
different intermediates.  Protection of the tertiary alcohol of 3.126 was accomplished with 
TESOTf and 2,6-lutidine (Scheme 3.36), which was followed by cleavage of the benzyl ether 
protecting group to provide secondary alcohol 3.127.  Oxidation under Parikh-Doering 
conditions followed by an unselective aldol reaction with aldehyde 3.7 afforded aldol adduct 
3.128 in low yields (33%).  This lower, unoptimized yield in the aldol reaction was attributed 
to slower enolization of the protected ketone substrate, as the ketone starting material was 
recovered.  Nonetheless, the resultant secondary alcohol 3.128 was exposed to ketalization 























3.121 R = TMS






























Scheme 3.35 : Attempts to protect the C14 tertiary alcohol as a silyl ether
R = TES, 77%
R = TMS 35%
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predominantly, along with unidentified decomposition products.  Reexposure of hemiketal 
3.129 to the reaction conditions employing excess trimethyl orthoformate and PPTS led to 
eventual deprotection of the TES protecting group and formation of the mixed methyl ketal 
3.108.  
 
 Due to the inability to protect the C14 tertiary alcohol and advance to the mixed 
methyl ketal, a protection of one of the diastereomers of the intermediate diol 3.108 as the 
bis silyl ether, followed by selective deprotection of the secondary TES ether was attempted 
(Scheme 3.37).  Alcohol 3.108 was treated with TESOTf and 2,6-lutidine.  It appeared that 
the product of this reaction was bis silyl ether 3.130 wherein the mixed methyl ketal was 
hydrolyzed to the hemiketal, which did not occur in prior attempts to protect ketone 3.120 
(Scheme 3.35).  Subjection of hemiketal 3.130 to monodeprotection conditions (catalytic 
PPTS/MeOH), resulted in the formation of a new product, which contained one triethylsilyl 




































































was exposed to either Swern or Parikh-Doering oxidation conditions, which had previously 
been successful at oxidizing similar substrates, only starting material was recovered with 




1.4 Attempts to protect the C14 tertiary alcohol as  the PMB ether   
 Because the TES ether was being cleaved during ketalization conditions (Scheme 
3.36), a more robust protecting group was explored.  It was believed that a PMB protecting 
group or a TBS protecting group should be used to protect the tertiary alcohol of C14.  A 
PMB ether was viewed as being the ideal protecting group in this case as it would be easier 
to cleave because oxidative conditions could be used, whereas a tertiary TBS group could 
potentially be difficult to cleave under mild conditions in the presence of sensitive functional 
groups in later steps.  Additionally, the PMB ether at C14 could be deprotected during the 
same step as the deprotection of the C19 PMB ether, so an additional deprotection step 
would not be necessary.  Furthermore, future Yamaguchi esterification should selectively 
occur at the less hindered secondary alcohol at C19.    
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 Conditions to successfully protect the tertiary alcohol at C14 in the presence of a 
ketone were explored (Table 3.6).  Unfortunately, at this juncture, none of the conditions 
explored (NaH and PMBCl, PMB-acetimidate and cat. TfOH) led to the formation of the 
desired product.   
 
 
     
  
Entry  Conditions  Result  
1 NaH, PMBCl, DMF Decomposition 





 A model system was prepared in order to identify appropriate protection conditions at 
an earlier intermediate (Scheme 3.38).  The model system was prepared from a cross 
metathesis of previously prepared enone 3.50 and 1-dodecene (3.134), followed by a 
chelation controlled addition with MeMgBr to arrive at tertiary alcohol 3.136.  Exposure of 
the tertiary alcohol to PMB protection conditions employing NaH, PMBCl and DMF did not 
result in the formation of the PMB ether 3.137 at room temperature or heating (Table 3.7, 
entries 1 and immediate removal of the ice bath upon addition of MeOTf led to 
decomposition (Table 3.7, entry 3).  Maintaining the temperature at 0 °C for during the 















































1 2.0 equiv. 
Dudley 
reagent, 2.0 
equiv. MeOTf, 2.0 equiv. MgO were used.  2 2.0 equiv. Dudley regent were used. 3 Product was significantly tainted with a 
byproduct from the reaction. 45.0 equiv. Dudley, 5.0 equiv. MeOTf, and 10 equiv. of MgO were used.  
 
remaining; however, upon workup, the product and starting material both appeared to 
decompose (Table 3.7, entry 4).  Different conditions and workups were also surveyed.  
Maintaining the temperature at 0 °C for the duratio n of the reaction, and employing 5 equiv. 
of the Dudley reagent, 5 equiv. of MeOTf, and 10 equiv. of MgO and skipping the workup 
generated the product in 60% yield, but this was significantly tainted with a byproduct from 
the reaction (Table 3.7, entry 6). Paquette's conditions, employing catalytic CSA in DCM 























PhCF3 0 °C 60%
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Scheme 3.38 : Preparation of a model system
Table 3.7 : Efforts directed toward the protection of tertiary alcohol 3.136










seemed to generate the product very slowly in low yields, but, once again, with a significant 
byproduct formation (Table 3.7, entry 5).38        
 
1.5 Protection of the C14 tertiary alcohol as the TBS e ther 
 Because of the difficulty associated with protecting the C14 tertiary alcohol of 3.136 
as the PMB ether, the benzyl ether of 3.136 was reductively cleaved to afford diol 3.139 in 
66% yield (Scheme 3.39).  Oxidation of the diol furnished ketone 3.140 which was protected 
as the TBS ether 3.141.  Enolization of 3.141 for 3 h, followed by addition of aldehyde 3.7 
delivered aldol adduct 3.142 as a 1:1 mixture of diastereomers.   One of the diastereomers 
from the aldol addition was arbitrarily subjected to ketalization condtions (10 mol % PPTS, 
20 equivalents of trimethyl orthoformate, and MeOH).  As before, hemiketal 3.143 was 
formed predominantly.  Exposure of hemiketal 3.143 to oxidation conditions provided a low 
yield of ketone 3.144.  Subsequently, upon treatment of ketone 3.144 to Wittig olefination 
conditions, no desired product was formed.  This could be due to the instability of the lactol 
of 3.144, as lactols are known to undergo olefinations when exposed to Wittig olefination 
conditions.39            
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 There are several key points that deserve comment.   Ketalization to form the mixed 
methyl ketal utilizing conditions (PPTS, MeOH, and trimethyl orthoformate) which were 
successful in other syntheses by the Crimmins group,40 and others41 failed to generate the 
desired mixed methyl ketal in good yields, and always gave the hemiketal as the major 
product.  The only exception to this was when the tertiary alcohol at C14 was unprotected, 
and then the desired mixed methyl ketal product was obtained predominantly.  In order to 
introduce the exocyclic olefin, it appeared as though the hemiketal should be protected as 
the mixed methyl ketal, given the results of the Wittig olefination of 3.144 (Scheme 3.39).  
Additionally, the mixed methyl ketal was a deemed a necessity for the future Yamaguchi 
esterification step, as Horne and coworkers had only limited success when trying to form an 
ester in the presence of the C13 unstable hemiketal, but saw an improvement in yield of the 









































































Scheme 3.39 : Efforts toward the installation of an exocyclic methylene








(Scheme 2.5).30  Therefore, it was believed that once a successful ketalization to form mixed 
methyl ketal was developed, the olefination to install the exocyclic methylene of 
iriomoteolide 1a should proceed smoothly, as should the subsequent Yamaguchi 
esterification.30 A test reaction of model substrate 3.142 utilizing CSA/MeOH formed the 
desired mixed methyl ketal 3.146 (Scheme 3.40, A).  However, because this reaction was 
successful, it would mean a change in protecting groups was necessary, as secondary TBS 
groups (which was protecting the C22 hydroxyl of the actual system) are cleaved in the 
presence of CSA/MeOH, and this could be problematic in later steps if deprotection of the 
C22 TBS ether were to occur (Scheme 3.40, B). 
 
1.6 Successful installation of the C11 exocyclic ol efin 
 To test this hypothesis, the TBS ether was replaced as the TIPS ether following aldol 
addition to provide 3.147 (Scheme 3.41).  Cleavage of the auxiliary revealed primary alcohol 
3.148 which was converted to the mesylate according to the previously established protocol.  
Treatment with KCN for 2 days at 55 °C generated the  unstable nitrile 3.149, which was 
immediately exposed to reducing conditions employing i-Bu2AlH to arrive at aldehyde 3.150 
in 74% for two steps.  At this juncture, aldehyde 3.150 was utilized in an Evans syn aldol 


































Loss of 2°TBS group?









Reductive cleavage of the auxiliary was accomplished utilizing LiBH4 and MeOH in Et2O to 













 Exposure of diol 3.152 to catalytic PPTS and anisaldehyde dimethyl acetal formed 
the PMP acetal, which was regioselectively opened with i-Bu2AlH to install the secondary 
PMB ether of 3.153 (Scheme 3.42).  Mesylation of the resultant primary alcohol, followed by 
nucleophilic displacement of the mesylate generated terminal olefin 3.156 in 85% yield over 
two steps.  Cross metathesis with Hoveyda-Grubbs second generation catalyst and enone 
3.50 provided enone 3.156, which was subjected to a chelation controlled addition with 
methyl Grignard to form a tertiary alcohol in 76% yield and as a 20:1 mixture of 
diastereomers.  Reductive removal of the benzyl protecting group was accomplished with 




























CH2Cl2, 0 °C to rt
97%
2. KCN



















































 The stereochemistry of the tertiary alcohol was proven by subjecting diol 3.157 to 
1,1-dimethoxypropane and catalytic CSA to provide the acetonide 3.158 in 69% yield.  
NOESY correlations between C14 methyl group and the C13 hydrogen, and the C13 methyl 
group and the C15 hydrogen provided strong evidence to support the validity of the 
assigned structure of 3.158.  
 
 Diol 3.157 was next converted to ketone 3.159 by oxidation under Parikth-Doering 
conditions, followed by protection of the tertiary alcohol as the TBS ether to generate 3.160. 




























































































aldehyde 3.7 (2 equiv) generated the product (1:1 d.r., inseparable) 3.161 in moderate 
yields (Scheme 3.44).  Ketalization was successful employing 10 mol % triphenyl 
phosphonium hydrobromide salt42 as which furnished a mixture of diasteromeric mixed 
methyl ketals 3.162 in 51% yield.  The mixture of diastereomers was oxidized under Ley's 
conditions,43 providing ketone 3.163, which upon exposure to 10 equiv. of the Tebbe reagent 
at -20 °C, underwent smooth olefination to install th e exocyclic olefin of 3.164 in 77% yield.  
Protection of the C14 tertiary alcohol proved to be vital to the success for the C11 







1.7 Proposed completion of iriomoteolide 1a 
 To complete the synthesis, the PMB ether of 3.163 will be cleaved to reveal 
secondary alcohol 3.165 (Scheme 3.45).  The secondary alcohol will be treated under 
Yamaguchi's conditions44 with acid 3.110 to afford ester 3.166.  Global deprotection of the 
silyl ethers followed by a ring closing metathesis with Grubbs 2nd generation catalyst will 
provide the proposed structure of iriomoteolide 1a. 
 
G. Summary 
 In conclusion, a concise and convergent synthesis to the core of iriomoteolide 1a has 
been developed.  Key steps include four thiazolidinethione mediated aldol additions to 
generate 7 of the 9 stereocenters of iriomoteolide 1a, a chelation controlled addition with 
methyl magnesium bromide to form the tertiary alcohol at C14 in high diastereoselectivity, 
and a Tebbe olefination to install the exocyclic olefin at C11.  Initially, our approach to 
iriomoteolide 1a relied on the formation of the C1-C11 fragment through cross metathesis.  













































with difficulties in the selective deprotection of a primary triethylsilyl ether over a secondary 
triethylsilyl ether, an alternative strategy which will employ ring closing metathesis to form 
the C6-C7 E-olefin has been exploited to deliver advanced intermediate 3.164, which can be 
transformed into the proposed structure in four additional steps.  Once the proposed 
structure of iriomoteolide 1a is completed, diastereomers will be synthesized in an effort to 
elucidate the actual structure of the natural product. 
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Experimental Information and NMR Spectra for Chapte r 1 
Infrared (IR) spectra were obtained using a JACSO FT/IR 460-plus spectrometer. Proton 
and carbon nuclear magnetic resonance (1H and 13C NMR) spectra were recorded on the 
following instruments: Bruker Avance 400 (1H at 400 MHz; 13C at 100 MHz), Bruker AMX 
300 (1H at 300 MHz) and Bruker DRX 500 (
1
H at 500 MHz; 
13
C at 125 MHz).  Multiplicities 
are reported as (s) singlet, (d) doublet, (t) triplet, (q) quartet, (m) multiplet, and (b) band.  
Optical rotations were determined using a JACSO P1010 polarimeter. Mass spectra were 
obtained using a Micromass Quattro II (triple quad) instrument with nanoelectrospray 
ionization. Thin layer chromatography (TLC) was conducted on silica gel 60 F254 TLC plates 
purchased from Dynamic Absorbants, Inc. Flash chromatography was carried out using 
silica gel (60 Å, 40 to 63 µm) purchased from Dynamic Absorbants, Inc. Dichloromethane 
(CH2Cl2) was dried by passing through a column of neutral alumina under nitrogen 
immediately prior to use. Alkylamines were distilled from calcium hydride immediately prior 
to use.  Titanium tetrachloride was distilled prior to use and stored under argon.  All other 
reagents and solvents were used as received from the manufacturer. All air and water 











To a stirring solution of aldehyde 65 (130 mg, 1.16 mmol) in 5 mL MeOH was added p-
TsOH (2 mg).  After 8 h, the reaction was quenched by the addition of saturated aqueous 
sodium bicarbonate solution and extracted into Et2O (3 x 10 mL).  The organic layer was 
sequentially washed with NaHCO3 (1 x 10 mL), water (2 x 10 mL), and brine (2 x 10 mL).  
The organic layer was dried (MgSO4) and concentrated at reduced pressure in an ice bath.  
The product was isolated by Kugelrohr distillation (55 mmHg, 100 °C) to give 180 mg of 
acetal 59 (87%).  1H NMR (300 MHz, CDCl3)  δ 5.51-5.40 (band, 2H), 4.07 (d, J = 6.3, 1H), 
3.37 (s, 6H), 2.23-2.18 (m, 1H), 1.85-1.77 (m, 1H), 1.69 (d, J = 4.8, 3H), 0.91 (d, J = 6.3, 
3H); 13C NMR (100 MHz, CDCl3) δ 129.12, 126.52, 108.46, 54.08, 53.90, 36.01, 35.08, 
17.93, 14.11;  IR (thin film) ν 2962(w), 2922(w), 2112(w), 1782(m), 1644(s), 1462(m), 







A solution of thione 60 (962 mg, 4.43 mmol) in 44 mL CH2Cl2 was cooled to 0 °C.  Neat TiCl 4 
(0.53 mL, 4.86 mmol) was added dropwise, and the resulting slurry was stirred for 5 min.  
The reaction was then cooled to -78 °C and i-Pr2NEt (0.85 mL, 4.86 mmol) in 1 mL of 
CH2Cl2 was added dropwise.  The resulting dark red solution was warmed to -40 °C and 
stirred for 2 h.  After 2 h, the reaction was cooled to -78 °C and freshly distilled, neat SnCl 4 
(0.26 mL, 2.21 mmol) was added dropwise, followed by the addition of acetal 59 (350 mg, 








-78 °C for an additional 15 min, and then transferr ed into a -20 °C bath where it was allowed 
to stir for 2 h.  The reaction was then quenched by the addition of a saturated aqueous 
NH4Cl solution.  The layers were separated and the aqueous layer was then extracted into 
CH2Cl2 (2 x 30 mL).  The organic extracts were dried (Na2SO4) and evaporated to give a 
crude yellow oil which was purified by flash chromatography (10% CH2Cl2/hexanes to 60% 
CH2Cl2/hexanes) to afford 490 mg of the product 81 (64%), a yellow oil.     
1H NMR (400 
MHz, CDCl3) δ 5.51 (m, 2H), 5.30 (ddd, J = 6.8, 6.8, 0, 1H), 5.16 (m, 1H), 3.38 (s, 3H), 3.00 
(dd, J = 11.2, 0, 1H), 2.36 (m, 1H), 2.31 (m, 1H), 2.21 (m, 1H), 2.04 (m, 1H), 1.69 (d, J = 5.6, 
4H), 1.09 (d, J = 6.8, 3H), 1.05 (d, J = 6.8, 3H), 1.02 (d, J = 6.8, 3H ), 0.89 (d, J = 6.8, 3H); 
13C NMR (100 MHz, CDCl3) δ 202.61, 177.22, 129.94, 126.50, 86.09, 71.67, 60.83, 41.46, 
37.90, 35.37, 30.54, 29.22, 19.00, 17.88, 17.32, 14.95, 12.93; IR (thin film) ν 2964(m), 
2933(m), 1698(s), 1454(m), 1373(m), 1313(w), 1254(m), 1155(s), 1088(m), 1046(w), 
1015(w); [α]22D = +51 (c = 0.36, CH2Cl2); MS (ESI) calculated for C17H29NO2Si2 [M+Na]+: 




 A solution of thiazolidinethione 81 (417 mg, 1.2 mmol) in CH2Cl2 (12 mL) was cooled to -78 
°C.  A 1 M solution of i-Bu2AlH in hexanes (2.40 mL, 2.40 mmol) was added slowly dropwise 
to the reaction mixture until the yellow color disappeared.  The reaction was immediately 
quenched by the addition of saturated aqueous Na/K tartrate solution, and allowed to warm 
to room temperature and stir at room temperature for 1 h.  The layers were then separated 
and the aqueous layer extracted with CH2Cl2.  The organic extracts were dried (Na2SO4), 
evaporated, and eluted through a plug of silica (8% EtOAc/hexanes to 50% EtOAc/hexanes) 
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to give 194 mg of the product 55 (88%), a colorless oil which was used immediately.   1H 
NMR (400 MHz, CDCl3) δ 9.81 (d, J = 2.4, 2H), 5.51 (band, 2H), 3.42 (s, 3H), 3.29 (dd, J = 
4.0, 7.2, 1H), 2.67 (ddddd, J = 9.2, 9.2, 9.2, 6.8, 2.4, 1H), 2.19 (m, 1H), 1.98 (m, 1H), 1.79 
(m, 1H), 1.70 (dd, , J = 6, 0.8, 3H), 1.07 (d, J = 6.8, 3H), 0.94 (d, J = 6.8, 3H); 13C NMR (100 
MHz, CDCl3) δ 204.78, 129.29, 126.92, 85.82, 60.40, 49.23, 37.00, 36.10, 17.90, 13.76, 
11.47; IR (thin film) ν 2965(s), 2933(s), 1724(m), 1456(m), 1378(w), 1258(w), 1156(w), 






A solution of thione 44 (154 mg, 0.56 mmol) in 6 mL CH2Cl2 was cooled to 0 °C.  TiCl 4 (60 
µL, 0.56 mmol) was added dropwise and the reaction was allowed to stir 5 min.  The 
reaction was then cooled to -78 °C and iPr2NEt (100 µL, 0.56 mmol) in 1 mL of CH2Cl2 was 
added dropwise.  The reaction was allowed to warm to -40 °C and enolize for 2 h.  After 2 h, 
the reaction was recooled to -78 °C and aldehyde 55 (68 mg, 0.37 mmol) was added as a 
solution in 1mL of CH2Cl2.   After 4 h, the reaction was quenched with half saturated NH4Cl 
solution and the layers were separated.  The aqueous layer was further extracted with 
CH2Cl2 (3x), and the organic extracts were dried (Na2SO4) and concentrated in vacuo.  The 
crude material was purified via flash column chromatography (10% EtOAc/hexanes) to yield 
150 mg of a yellow oil 16 (88%).  1H NMR (400 MHz, CDCl3) δ 6.86 (s, 2H),  6.44 (dd, J = 
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9.6, 9.6, 1H), 5.45 (b, 2H), 4.34 (brd, 1H), 3.72 (dd, J = 17.2, 9.2, 1H), 3.62 (dd, J = 11.2, 
11.2, 1H), 3.43 (s, 3H), 3.37 (dd, J = 11.2, 9.2, 1H), 3.15 (m, 2H), 3.02 (dd, J = 7.2, 4.8, 1H), 
2.42 (bds, 6H), 2.25 (s, 3H), 2.02 (m, 1H), 1.99 (m, 1H), 1.84 (m, 1H), 1.68 (m, 3H), 1.47 (m, 
1H), 0.88 (d, J = 6.8, 3H), 0.83 (d, J = 6.8, 3H); 13C NMR (100 MHz, CDCl3) δ 201.50, 
174.59, 137.79, 132.70, 129.74, 126.35, 87.90, 68.14, 67.50, 61.51, 45.07, 39.30, 37.43, 
35.88, 32.50, 20.74, 20.22, 17.93, 13.58, 10.96; IR (thin film) ν 3477(s), 2964(s), 2927(s), 
1708(s), 1611(w), 1455(m), 1372(m), 1330(w), 1260(m), 1181(m), 1128(w), 1088(w); [α]25D 
= +84.3 (c = 0.45, CH2Cl2); MS (ESI) calculated for C25H37 NO3S2 [M+Na]






To a solution of alcohol 82 (321 mg, 0.69 mmol) in CH2Cl2 (6 mL) at 0 °C was added freshly 
distilled 2, 6-lutidine (160 µL, 1.39 mmol) followed by dropwise addition of neat TESOTf (242 
µL, 1.07 mmol).  After addition was complete, the ice bath was removed and the reaction 
was allowed to stir for an additional hour at room temperature.  The reaction was quenched 
with a saturated aqueous NaHCO3 solution and the layers were separated.  The aqueous 
layer was extracted with CH2Cl2 (3x), and the combined organic extracts were dried 
(Na2SO4) and concentrated in vacuo.  The crude yellow residue was purified by flash column 
chromatography (1% EtOAc/hexanes to 3% EtOAc/hexanes) to obtain 385 mg of a yellow 
102 
 
oil 83 (96%).   1H NMR (400 MHz, CDCl3) δ 6.82 (s, 2H), 6.40 (dd, J = 10.2, 10.2, 1H), 5.42 
(b, 2H), 4.55 (m, 1H), 3.71 (dd, J = 18, 5.2, 1H), 3.59 (dd, J = 10.8, 10.8, 1H), 3.39 (dd, J = 
12, 0, 1H), 3.35 (s, 3H), 3.22 (dd, J = 18, 9.2, 1H), 3.00 (J = 8, 1H), 2.41 (brs, 6H), 2.22 (s, 
3H), 2.06 (m, 1H), 1.93 (m, 1H), 1.67 (d, J = 5.6, 3H), 1.52 (m, 1H), 0.97 (b, 10H), 0.63 (b, 
12H); 13C NMR (100 MHz, CDCl3) δ 200.64, 172.79, 137.69, 132.32, 130.47, 125.93, 84.26, 
68.01, 67.83, 60.28, 45.90, 39.48, 38.27, 35.59, 32.33, 20.62, 20.12, 17.82, 12.50, 9.69, 
6.93, 5.45; IR (thin film) ν 2958(s), 2876(s), 2731(w), 1713(s), 1611(w), 1456(m), 1403(w), 
1371(m), 1329(w), 1302(w), 1260(m), 1177(m), 1124(w), 1091(w), 1062(w), 1017(m); [α]24D 
= +20 (c = 0.71, CH2Cl2); MS (ESI) calculated for C31H51NO3S2Si [M+H]





A solution of the thione 83 (155 mg, 270 mmol) in CH2Cl2 (3 mL) was cooled to -78 °C.  A 1 
M solution of i-Bu2AlH in hexanes (540 µL, 540 mmol) was added dropwise until the yellow 
color disappeared.  The reaction was immediately quenched by the addition of a saturated 
aqueous sodium potassium tartrate solution and allowed to warm to room temperature with 
vigorous stirring.  The reaction mixture was allowed to stir at room temperature for an 
additional hour or until the emulsion had dispersed.  The layers were then separated and the 
aqueous layer was further extracted with CH2Cl2 (3x).  The organic extracts were combined, 
dried (Na2SO4), and the solvent removed to afford a residue containing crystalline 
thiazolidinethione and the aldehyde.  The crude product was purified via column 
chromatography (10% EtOAc/hexanes to 50% EtOAc/hexanes) to afford 83.5 mg of 
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aldehyde 56 (91%) which was used immediately in the next reaction.  1H NMR (400 MHz, 
CDCl3) δ 9.79 (dd, J = 2.4, 2.4, 1H), 5.49-5.37 (m, 2H),  4.65 (ddd, J = 6.4, 6.4, 2, 1H), 3.50 
(s, 3H), 3.16 (dd, J = 1.6, 9.2, 1H), 2.67 (ddd, J =  2.4, 7.2, 16, 1H), 2.61 (ddd, J = 2.4, 6.4, 
15.6, 1H), 2.18 (m, 1H), 2.06 (m, 1H), 1.70 (m, 1H), 1.69 (d, J = 5.6, 3H), 1.57 (m, 1H), 1.00 
(t, J = 8, 9H), 0.84 (d, J = 7.2, 3H), 0.82 (d J = 6.8, 3H), 0.664 (q, J = 8, 6H); 13C NMR (100 
MHz, CDCl3) δ 201.38, 130.27, 126.41, 84.37, 67.27, 60.64, 50.78, 42.28, 38.37, 35.67, 
17.89, 12.90, 10.22, 6.91, 5.48; IR (thin film) ν 2959(s), 2912(s), 2877(s), 2718(w), 2359(m), 
1728(s), 1456(m), 1415(w), 1381(w), 1240(w), 1134(w), 1090(m), 1016(w); [α]23D = -5 (c = 
0.6, CH2Cl2); MS (ESI) calculated for C19H38O3Si [M+Na]






To a 0 °C solution of thione 57 (193 mg, 0.69 mmol) was added TiCl4 (70 µL, 0.69 mmol).  
After 20 min of stirring at 0 °C, (-)-sparteine (160  µL, 0.69 mmol) was added dropwise to the 
yellow slurry and the solution turned a deep black color.  After 20 min more of stirring at 0 
°C, N-methyl-2-pyrrolidone (67 µL, 0.69 mmol) was added and the reaction was stirred at 0 
°C for 20 min.  After 20 min, the reaction was cooled to -78 °C and aldehyde 56 (70 mg, 
0.20 mmol) was added in 500 µL CH2Cl2.  The flask containing the aldehyde was rinsed with 
an additional 500 µL CH2Cl2 and added to the reaction flask.  The reaction was allowed to 
warm slowly to -50 °C, and stir overnight.  The reacti on was then quenched with saturated 
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aqueous NH4Cl solution.  The layers were separated, and the aqueous layer was further 
extracted with CH2Cl2 (3x).  The combined organic extracts were dried (Na2SO4) and 
evaporated to give a crude yellow residue which was purified by column chromatography 
(8% EtOAc/hexanes to 20% EtOAc/hexanes) to yield 83 mg alcohol 84 (65%).  1H NMR 
(500 MHz, CDCl3) δ 7.37-7.29 (band, 5H), 5.47-5.35 (b, 3H), 4.93 (m, 1H), 4.17 (brd, 1H), 
4.11 (m, 1H), 3.47 (s, 3H), 3.38 (dd, J = 5.6, 9.2, 1H), 3.30 (m, 1H), 3.15 (m, 3H), 2.88 (dd, J 
= 9.2, 0, 1H), 2.17 (m, 1H), 2.02-1.95 (b, 2H), 1.88 (m, 1H), 1.79 (b, 6H), 1.03 (b, 12H), 0.88 
(d, J = 3.6, 3H), 0.85 (d, J = 4, 3H), 0.67 (q, J = 6.4, 6H); 13C NMR (100 MHz, CDCl3) δ 
201.79, 172.26, 136.58, 130.25, 129.42, 128.88, 127.18, 126.51, 84.59, 71.58, 70.23, 69.38, 
60.14, 50.37, 40.68, 39.69, 38.69, 36.83, 35.46, 31.81, 19.93, 18.00, 13.48, 7.02, 5.36; IR 
(thin film) ν 3439(br), 2959(s), 2359(w), 1693(m), 1455(m), 1340(w), 1263(m), 1190(w), 
1163(m), 1135(w), 1034(w); [α]23D = +60.8 (c = 0.6 CH2Cl2); MS (ESI) calculated for C33H35 
NO4S2Si [M+Na]





To a solution of alcohol 84 (26 mg, 0.042 mmol) in CH2Cl2 (1 mL) at 0 °C was added 2,6-
lutidine (10 µL, 0.084 mmol) followed by addition of TESOTf (14 µL, 0.063 mmol).  The 
reaction was allowed to slowly warm to room temperature and stir.  After 1 h, the reaction 
was quenched with saturated aqueous NaHCO3 solution and the layers were separated.  
The aqueous layer was further extracted with CH2Cl2.  The organic layers were combined, 
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dried (Na2SO4) and the solvent removed in vacuo to yield a crude yellow residue which was 
further purified by column chromatography (3% EtOAc/Hexanes) to obtain 28.6 mg of silyl 
ether 85 (93%), a yellow oil.  1H NMR (400 MHz, CDCl3) δ 7.38-7.28 (b, 5H), 5.52-5.39 (b, 
2H), 5.27 (dddd, J = 8.5, 8.5, 3.2, 3.2, 1H), 4.78 (m, 1H), 4.13 (m, 1H), 4.03 (dd, J = 5.6, 
11.2, 1H), 3.47 (s, 3H), 3.36-3.32 (m, 2H), 3.16 (dd, J = 9.6, 0, 1H), 3.11 (dd, J = 10.8, 12.8, 
1H), 2.87 (dd, J = 11.2, 0, 1H), 2.18 (m, 1H), 2.04-1.88 (b, 3H), 1.84 (m, 1H), 1.78-1.57 (b, 
6H), 1.05 (b, 21H), 0.85 (d, J = 7.2, 3H), 0.77 (d, J = 6.8, 3H), 0.69 (b, 12H); 13C NMR (100 
MHz, CDCl3) δ 200.94, 175.88, 136.92, 130.72, 129.47, 128.86, 127.09, 126.10, 84.34, 
71.18, 69.70, 69.45, 60.86, 51.45, 42.26, 40.55, 38.58, 36.66, 35.80, 31.98, 21.41, 17.91, 
12.88, 11.91, 9.66, 7.12, 7.00, 6.03, 5.25; IR (thin film) ν 2957(s), 2912(s), 2876(s), 1696(m), 
1604(w), 1495(w), 1456(m), 1414(w), 1379(w), 1340(m), 1318(w), 1292(w), 1263(w), 
1190(m), 1164(s), 1134(w), 1084(w), 1040(m), 1010(m); [α]23D = +81.2  (c = 1.6, CH2Cl2); 
MS (ESI) calculated for C39H69 NO4S2Si2 [M+Na]






A solution of silyl ether 85 (60 mg, 0.082 mmol) in 2 mL CH2Cl2 was cooled to -78 °C.  A 1 M 
solution of iBu2AlH (0.16 mL, 0.16 mmol) in hexanes was added dropwise until the yellow 
color disappeared.  The reaction was immediately quenched by the addition of aqueous 
saturated sodium potassium tartrate solution, and allowed to warm to room temperature with 
vigorous stirring.  After dispersion of the emulsion, the layers were separated and the 
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aqueous layer was further extracted with CH2Cl2 (3x).  The combined organic extracts were 
dried (Na2SO4) and concentrated under vacuo.  The crude material, which contained the 
crystalline thione was purified via column chromatography (7% EtOAc/hexanes to 50% 
EtOAc/hexanes) to obtain 42 mg of the resultant aldehyde 55 (98%), a clear oil.  1H NMR 
(400 MHz, CDCl3) δ 9.74 (s, 1H), 5.50-5.39 (b, 2H), 4.15 (ddd, J = 7.2, 7.2, 2.4, 1H), 4.02 
(dd, J = 7.2, 7.2, 1H), 3.46 (s, 3H), 3.16 (dd, J = 9.6, 0, 1H), 2.20 (m, 2H), 2.05 (m, 1H), 1.87 
-1.80 (b, 3H), 1.68 (b, 4H), 1.54 (m, 2H), 1.01 (b, 21H), 0.83 (d, J =6.8, 3H), 0.77 (d, J = 6.8, 
3H), 0.65 (b, 12H); 13C NMR (100 MHz, CDCl3) δ 205.03, 130.57, 126.22, 84.26, 69.44, 
69.10, 60.89, 57.78, 40.38, 40.10, 38.44, 35.71, 17.89, 16.18, 12.65, 12.59, 9.22, 7.00, 6.80, 
5.85, 5.16; IR (thin film) ν 2958(s), 2877(s), 2360(m), 2341(m), 1726(m), 1458(s), 1415(s), 
1379(w), 1239(w), 1138(w), 1082(s), 1016(m); [α]22D = -6 (c = 0.54, CH2Cl2); MS (ESI) 
calculated for C29H60O4Si2 [M+H]




A solution of phosphonate 86 (261 mg, 0.814 mmol) in THF (10 mL) was cooled to 0 °C.  
NaI (94 mg, 0.625 mmol) was added, and the solution was allowed to stir 5 min.  NaH (33 
mg, 0.814 mmol) as a 60% dispersion in mineral oil was then added to the reaction mixture, 
and allowed to stir an additional 15m.  After 15m, the reaction flask was cooled to -78 °C, 
and aldehyde 55 (42 mg, 0.079 mmol) was added as solution in THF (500 µL).  The flask 
containing the aldehyde was washed with an additional 500 µL and transferred to the 
reaction flask.  The reaction mixture was allowed to slowly warm to room temperature over 
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2h.  After 2h, the reaction was quenched with saturated NH4Cl solution, the layers 
separated, and the aqueous layer extracted with EtOAc (3x).  The organic layer was then 
dried over Na2SO4, the solvent was evaporated and the crude material subjected to flash 
column chromatography ( 100% hexanes to 5% EtOAc/ Hexanes) to afford 40 mg of ester 
21 (83%), a clear oil.    1H NMR (400 MHz, CDCl3) δ 6.14 (dd, J = 10.4, 10.4, 1H), 5.87 (d, J 
= 12, 1H),  5.48 (m, 2H), 4.23 (b, 3H), 3.72 (m, 1H), 3.47 (s, 3H), 3.43 (m, 1H), 3.18 (dd, J = 
9.6, 0, 1H), 2.17 (m, 1H), 2.05 (m, 1H), 1.86 (m, 1H), 1.78-1.67 (b, 7H), 1.30 (b, 4H), 1.00 (b, 
26H), 0.76 (d, J = 6.4), 0.66 (b, 12H); 13C NMR (100 MHz, CDCl3) δ 166.08, 152.08, 130.85, 
126.03, 120.52, 84.44, 72.34, 69.35, 69.90, 59.70, 44.42, 41.20, 39.93, 38.61, 35.80, 21.58, 
17.96, 14.29, 12.76, 11.73, 9.36, 7.11, 6.99, 6.93, 5.98, 5.90, 5.30, 5.18; IR (thin film) ν 
2959(s), 2877(s), 2358(w), 1723(s), 1644(w), 1456(m), 1414(w), 1381(w), 1237(w), 1182(w), 
1182(m), 1088(m), 1016(m); [α]22D = -55 (c = 0.21, CH2Cl2); MS (ESI) calculated for 
C33H66O5Si2 [M+H]
+: 599.5, found 599.5. 
 
(-)-Pironetin 
Ester 87 (38.7 mg, 0.065 mmol) was dissolved in 1 mL of a 10:1 mixture of C6H6 and MeOH.  
To this mixture was added PPTS (1 mg).  The reaction was allowed to stir at room 
temperature for 3h, then it was heated to 60 °C and stirred for 3h.  After 3h, the solvent was 
removed and the crude material was subjected to flash column chromatography (25% 
EtOAc/hexanes to 40% EtOAc/hexanes) to obtain 13.2 mg of pironetin 1 (63%).   1H NMR 
(500 MHz, CDCl3) δ 7.05 (dd, J = 6, 10, 1H), 6.05 (d, J = 10, 1H), 5.48-5.36 (m, 2H), 4.77 
(m, 1H),  4.23 (brd, 1H), 3.49 (s, 3H), 3.48 (d, J = 2.5, 1H), 3.01 (dd, J = 4.0, 6.0, 1H), 2.30 
(m, 1H), 2.13 (m, 1H), 1.89 (m, 2H), 1.80 (m, 1H), 1.74-1.64 (b, 6H), 1.55 (m, 1H), 1.03 (d, J 
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= 7, 3H), 1.00 (t, J = 8, 3H), 0.982 (d, J = 7, 3H);  13C NMR (100 MHz, CDCl3) δ 164.65, 
150.60, 128.81, 126.90, 120.85, 91.14, 77.82, 67.47, 61.55, 39.15, 39.03, 37.30, 36.73, 
36.20, 20.79, 17.93, 15.23, 12.19, 11.00; IR (thin film) ν 3479(s), 2965(s), 2934(s), 1715(s), 
1457(m), 1381(m), 1315(w), 1256(m), 1138(w), 1094(m), 1027(m); [α]22D = -98 (c = 0.51, 
CHCl3); MS (ESI) calculated for C19H32O4 [M+H]
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Experimental Information and NMR spectra for Chapte r 3 
 
 Methods and Materials:   Infared (IR) spectra were obtained using a Jasco 460 
Plus Fourier transform infrared spectrometer and values reported in cm-1.  Proton and 
carbon nuclear magnetic resonance (1H and 13C NMR) spectra were recored on the Bruker 
400 (1H at 400 MHz; 13C at 100 MHz), Bruker 500 (1H at 500 MHz; 13C at 125 MHz), and 
Bruker 600 (1H at 600 MHz; 13C at 150 MHz).  Optical rotations were determined using a 
Jasco P1010 polarimeter.  Thin layer chromatography (TLC) was conducted on silica gel 
F254 TLC plates purchased from Silacycle.  Flash column chromatography was carried out 
using silica gel (32 µm) purchased from Scientific Absorbents, Inc.  Diethyl either (Et2O), 
tetrahydrofuran (THF), and dichloromethane (CH2Cl2) were dried by being passed throught a 
column of neutral alumina under nitrogen prior to use.  Alkylamines were distilled from 
calcium hydride immediately prior to use.  All other reagents and solvents were used as 
receieved from the manufacturer, unless otherwise specified.  All air and water sensitive 
reactions were performed in flaskes flame dried under a positive flow of argon and 










A solution of thione 3.9 (25 g, 94.3 mmol) in 940 mL CH2Cl2 was cooled to 0 °C.  Neat TiCl 4 
(10.9 mL, 99.03 mmol) was added dropwise, and the resulting orange slurry was stirred for 5 
min.  i-Pr2NEt was then added and the resultant black solution was stirred for 15 min.  N-
methyl-2-pyrrolidinone (18.1 mL, 188.6 mmol) was added dropwise at 0 °C and stirred.  
After 30 min, the reaction was cooled to -78 °C, and a cetaldehyde (10.7 mL, 188.6 mmol) 
was added dropwise.  Upon completion of the reaction by TLC analysis, the reaction was 
then quenched by addition of a saturated aqueous NH4Cl solution.  The layers were 
separated and the aqueous layer was then extracted into CH2Cl2 (2 x 200 mL).  The organic 
extracts were dried (Na2SO4) and evaporated to give a crude yellow oil which was purified 
by flash chromatography (10% EtOAc/hexanes to 20% EtOAc/hexanes) to afford 23.28 g of 
the product 3.10 (80%), a yellow oil.  1H NMR (400 MHz, CDCl3) δ 7.29-7.39 (m, 5H), 5.37 
(dddd, J = 3.6, 7.2, 1H), 4.43 (m, 1H), 4.16 (m, 1H), 3.42 (dd, J = 7.2, 11.6, 1H), 3.25 (dd, J 
= 3.6, 13.2, 1H), 3.07 (dd, J = 10.4, 13.2, 1H), 2.94 (d, J = 11.6, 1H), 2.755 (s, 1H), 1.30 (d, 
J = 6.8, 3H), 1.23 (d, J = 6.4, 3H); 13C NMR (100 MHz, CDCl3) δ 201.44, 178.55, 136.37, 
129.46, 128.95, 127.30, 68.79, 68.45, 44.41, 36. 78, 32.14, 20.25, 10.48; IR (thin film) ν 
3853, 3422, 3062, 3026, 2975, 2934, 2246, 1692, 1603, 1495, 1454, 1360, 1341, 1319, 
1292, 1261, 1192, 1166, 1135, 1093, 1033, 1001; [α]22D = -107 (c = 18.5, CH2Cl2); MS (ESI) 
calculated for C15H19NO2S2 [M+Na]







To a solution of secondary alcohol 3.10 (18.23 g, 60.0 mmol) at 0 °C was added 2,6-lutidine 
(14.0 mL, 120 mmol), followed by TIPSOTf (24.0 mL, 88.5 mmol).  After addition, the cooling 
bath was removed, and the reaction was allowed to warm to room temperature.  After 20 
min, the reaction was quenched by the addition of a saturated NaHCO3 solution.  The layers 
were separated, and the aqueous layer was further extracted into CH2Cl2 (3 x 100 mL).  The 
organic extracts were dried (Na2SO4) and evaporated to give a crude yellow oil which was 
purified by flash chromatography (100% hexanes to 5% EtOAc/Hexanes) to provide 24.1 g 
of the product 3.147 (94%).  1H NMR (500 MHz, CDCl3) δ 7.38 (m, 5H), 5.23 (m, 1H), 4.63 
(m, 1H), 4.34 (m, 1H), 3.34 (m, 2H), 3.09 (dd, J = 11, 11, 1H), 2.91 (d, J = 11.5, 1H), 1.29 
(m, 6H), 1.07 (s, 21H); 13C NMR (125 MHz, CDCl3) δ 201.26, 176.63, 136.75, 129.52, 
128.91, 127.17, 71.09, 69.57, 46.34, 36.51, 31.98, 21.35, 18.20, 18.13, 12.71, 12.02; IR 
(thin film) ν 2942, 2865, 1703, 1455, 1341, 1257, 1191, 1030; [α]22D = -57.8 (c = 8.15, 
CH2Cl2); MS (ESI) calculated for C24H39NO2S2Si [M+Na]




To a stirring solution of TIPS ether 3.147 (24.1 g, 52.3 mmol) in Et2O (520 mL) at 0 °C was 
added MeOH (3.2 mL, 78.5 mmol).  A solution of LiBH4 (2M in THF, 39.27 mL, 78.5 mmol) 
was added slowly dropwise.  The reaction was allowed to stir overnight, while warming to 
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room temperature.  The following day, the reaction was recooled to 0 °C and a saturated 
solution of NaHCO3 was added slowly.  Upon separation of the layers, the aqueous layer 
was further extracted with Et2O (3 x 200 mL), and dried over MgSO4.  The organic extracts 
were concentrated to provide a crude oil containing solidified chiral auxiliary which was 
purified by flash chromatography (2% EtOAc/CH2Cl2) to provide 10.8 g of alcohol 3.148 
(80%)   1H NMR (500 MHz, CDCl3) δ 4.13 (m, 1H), 3.80 (m, 1H), 3.55 (m, 1H), 3.38 (s, 1H), 
2.15 (m, 1H), 1.22 (d, J = 6, 3H), 1.09 (m, 22H), 0.79 (d, J =7, 3H); 13C NMR (125 MHz, 
CDCl3) δ 73.13, 65.44, 40.61, 18.08, 18.03, 17.63, 12.97, 12.33; IR (thin film) ν 3375, 2942, 
2867, 1463, 1383, 1245, 1159, 1109, 1047; [α]22D = +3.1 (c = 19.7, CH2Cl2); MS (ESI) 
calculated for C14H32O2Si [M+Na]
+: 283.2, found 283.2. 
 
 
(2S,3S)-2-methyl-3-(triisopropylsilyloxy)butyl meth anesulfonate 
A solution of primary alchol 3.148 (10.8 g, 41.5 mmol) in CH2Cl2 (415 mL) was cooled to 0 
°C.  Triethylamine (8.7 mL, 62.3 mmol) was added dro pwise, followed by the addition of 
freshly distilled methane sulfonyl chloride (3.85 mL, 49.8 mmol).  The reaction was allowed 
to stir overnight while warming to room temperature.  The following day, the reaction was 
quenched by the addition of a saturated NaHCO3 solution.  The layers were separated, and 
the aqueous layer was extracted into CH2Cl2 (2 x 100 mL).  The organic extracts were dried 
(Na2SO4), and evaporated to give a clear crude oil, which was purified by flash 
chromatography (10% EtOAc/hexanes to 20% EtOAc/hexanes) to give 13.4 g of the 
mesylate (96%).     1H NMR (400 MHz, CDCl3) δ 4.39 (dd, J =6, 9.2, 1H), 4.17 (m, 2H), 3.02 
(s, 3H), 2.07 (m, 1H), 1.19 (d, J = 6.4, 3H), 1.09 (m, 24H), 1.01 (d, J = 7.2); 13C NMR (100 
MHz, CDCl3) δ 72.20, 68.59, 40.47, 37.14, 20.06, 18.18, 18.13, 12.61, 11.41; IR (thin film) ν 
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3582, 2943, 2867, 1463, 1359, 1247, 1178, 1105, 1051, 1014; [α]22D = +0.44 (c = 37, 
CH2Cl2); MS (ESI) calculated for C15H34O4SSi [M+Na]




The mesylate (13.4 g, 39.6 mmol) above was dissolved in DMSO (400 mL).  Potassium 
cyanide (5.15 g, 79.2 mmol) was added followed by TBAI (50 mg, 0.14 mmol).  The reaction 
was heated to 60 °C, and stirred at this temperature f or 2 days.  The reaction was quenched 
by the addition of water (200 mL), and the aqueous phase was extracted with Et2O (6 x 150 
mL).  The organic extracts were dried (MgSO4) and evaporated at 0 °C to deliver 10.7 g of 
crude nitrile 3.149. Crude nitrile 3.149 was immediately dissolved in CH2Cl2 (400 mL), and 
cooled to -78 °C.  Diisobutylaluminum hydride (1M solu tion in hexanes, 79.2 mL, 79.2 mmol, 
2 equiv.) was added dropwise.  The reaction was stirred at -78 °C for 3 h and quenched by 
the addition of a saturated sodium/potassium tartrate solution.  The layers were then 
separated, and the aqueous layer was extracted with CH2Cl2 (3 x 100 mL).  The organic 
extracts were dried (Na2SO4), and concentrated to provide a clear crude oil, which was 
purified by flash chromatography (5% EtOAc/hexanes) to deliver 8.00 g of aldehyde 3.150 
(74% for 2 steps). 1H NMR (400 MHz, CDCl3) δ 9.79 (dd, J = 2, 2, 1H), 3.96 (m, 1H), 2.68 
(ddd, J = 2, 5.2, 6.8, 1H), 2.32 (m, 1H), 2.20 (ddd, J = 2.4, 8.4, 10.8, 1H), 1.10 (m, 24H), 
0.92 (d, J = 6.8, 3H);13C NMR (100 MHz, CDCl3) δ 202.96, 71.25, 45.76, 35.46, 18.38, 
18.14, 18.10, 16.05, 12.49; IR (thin film) ν 2943, 2867, 2714, 2360, 1727, 1566, 1462, 1382, 
1396, 1245, 1201, 1157,1120, 1100, 1047; [α]22D = +8.4 (c = 53.4, CH2Cl2); MS (ESI) 
calculated for C15H32O2Si [M+Na]







A solution of thione 19 (5.4 g, 18.55 mmol) in 186 mL CH2Cl2 was cooled to 0 °C.  Neat TiCl 4 
(2.14 mL, 19.05 mmol) was added dropwise, and the resulting slurry was stirred for 15 min.  
Hünig's base (3.55 mL, 20.4 mmol) was added dropwise, and the resulatant deep red 
solution was stirred for 15 m.  N-methyl pyrrolidinone (3.60 mL, 37.1 mmol) was added at 0 
°C.  After 30 min, aldehyde 3.150 was added dropwise in CH2Cl2 (10 mL).  The reaction was 
stirred 1 h, and was quenched by the addition of a saturated NaHCO3 solution.   The layers 
were separated and the aqueous layer was then extracted into CH2Cl2 (2 x 30 mL).  The 
organic extracts were dried (Na2SO4) and evaporated to give a crude yellow oil which was 
purified by flash chromatography (10% EtOAc/hexanes) to afford 9.01 g of secondary 
alcohol 3.151 (86%), a yellow oil.  1H NMR (400 MHz, CDCl3) δ 7.31 (m, 5H), 5.97 (dddd, J 
= 16.8, 10.0, 6.8, 6.8, 1H), 5.40 (dddd, J = 7.2, 7.2, 3.6, 3.6, 1H) 5.10 (m, 3H), 4.19 (m, 1H), 
3.95 (m, 1H), 3.34 (dd, J = 7.2, 11.6, 1H), 3.24 (dd, J = 3.2, 13.2, 1H), 3.05 (m, 2H), 2.89 (d, 
J = 11.6, 1H), 2.73 (m, 1H), 2.62 (m, 1H), 2.00 (m, 1H ), 1.73 (m, 1H), 1.46 (m, 1H), 1.16 (m, 
24H), 0.92 (d, J = 7.2) 13C NMR (100 MHz, CDCl3) δ 201.39, 175.80, 136.61, 135.97, 
129.25, 128.91, 127.21, 116.77, 72.68, 70.85, 69.13, 48.08, 36.95, 36.75, 36.39, 31.52, 
31.30, 18.22, 18.15, 17.82, 12.54; IR (thin film) ν 3464, 3065, 3027, 2942, 2890, 2865, 
1692, 1640, 1603, 1495, 1455, 1364, 1341, 1319, 1293, 1260, 1190, 1160, 1134, 1037; 







To a stirring solution of secondary alcohol 3.151 (8.50 g, 15.1 mmol) in Et2O (151 mL) at 0 
°C was added MeOH (0.91 mL, 22.62 mmol).  A solution of LiBH4 (2M in THF, 11.31 mL, 
22.63 mmol) was added slowly dropwise.  The reaction was allowed to stir overnight, while 
warming to room temperature.  The following day, the reaction was recooled to 0 °C and a 
saturated solution of NaHCO3 was added slowly.  Upon separation of the layers, the 
aqueous layer was further extracted with Et2O (3 x 75 mL), and dried over MgSO4.  The 
organic extracts were concentrated to provide a crude oil containing solidified chiral auxiliary 
which was purified by flash chromatography (2.5% EtOAc/CH2Cl2) to provide 4.5 g of alcohol 
3.152 (83%).  1H NMR (400 MHz, CDCl3) δ 5.91 (dddd, J = 17.2, 10, 10, 7.2, 1H), 5.13 (dd, J 
= 17.2, 8, 2H), 4.15 (m, 1H), 3.98 (m, 1H), 3.85 (m, 1H), 3.74 (m, 1H), 3.22 (d, J =3.2, 1H), 
2.69 (m, 1H), 2.21 (ddd, J = 7.2, 0, 2H), 2.03 (m, 1H), 1.83 (m, 1H), 1.70 (s, 1H), 1.65 (m, 
1H ), 1.53 (m,1H), 1.16 (d, J = 6.4, 3H), 1.10 (m, 20H), 0.93 (d, J =7.2, 3H); 13C NMR (100 
MHz, CDCl3) δ 137.36, 116.20, 72.87, 72.39, 64.50, 43.95, 36.66, 35.20, 30.10, 18.17, 
18.10, 17.99, 17.78, 12.50; IR (thin film) ν 3854, 3751, 3397, 3077, 2942, 2890, 2866, 1640, 
1463, 1382, 1245, 1160, 1105, 1037; [α]22D = +9.43 (c = 20.1, CH2Cl2); MS (ESI) calculated 
for C20H42O3Si [M+Na]









A solution of diol 3.152 (2.14 g, 5.97 mmol) was dissolved in CH2Cl2 (60 mL).  Benzaldehyde 
dimethylacetal (1.53 mL, 9 mmol) was added followed by pyridinium p-toluenesulfonate 
(0.150 g, 0.60 mmol).  The reaction was stirred 2 h, quenched by the addition of 
triethylamine (0.5 mL), and concentrated.  The resultant crude oil was purified through a 
plug of silica (10% EtOAc/hexanes) to deliver the crude PMP acetal, which was dissolved in 
CH2Cl2 (60 mL) and cooled to -78 °C.  A solution of diisobut ylaluminum hydride (1M in 
hexanes, 12.0 mL, 12.0 mmol) was added dropwise, and allowed to slowly warm to room 
temperature.  After stirring 8 h, the reaction was quenched by the addition of a saturated 
sodium/potassium tartrate solution.  The layers were separated, and the aqueous layer was 
extracted with CH2Cl2 (2 x 25 mL).  The organic extracts were dried (Na2SO4) and 
evaporated to give a crude clear oil which was purified by flash chromatography (5% 
EtOAc/hexanes to 10% EtOAc/hexanes to 20% EtOAc/hexanes) to afford 1.90 g of the 
product 3.153 (70%), a clear oil.     1H NMR (400 MHz, CDCl3) δ 7.29 (d, J = 8.8, 2H), 6.91 
(d, J = 8.8, 2H), 5.88 (dddd, J = 17.2, 10, 7.2, 7.2, 1H), 5.10 (m, 2H), 4.55 (dd, J = 11.2, 
11.2, 1H), 3.87 (m, 1H), 3.83 (s, 3H), 3.75 (m, 3H), 2.84 (dd, J = 5.6, 5.6, 1H), 2.11 (m, 3H), 
1.87 (m, 1H), 1.67 (m, 1H), 1.47 (m, 1H), 1.11 (m, 25H), 0.93 (d, J = 6.8, 3H); 13C NMR (100 
MHz, CDCl3) δ 159.27, 137.10, 130.34, 129.61, 116.15, 113.84, 80.58, 71.99, 70.69, 63.94, 
55.20, 41.20, 38.08, 31.03, 30.71, 19.19, 18.29, 18.24, 16.10, 12.65; IR (thin film) ν 3434, 
2942, 2866, 1613, 1513, 1463, 1381, 1302, 1248, 1172, 1038; [α]22D = -3.5 (c = 17.5, 
CH2Cl2); MS (ESI) calculated for C28H50O4Si [M+Na]







A solution of primary alchol 3.153 (973 mg, 2.03 mmol) in CH2Cl2 (20 mL) was cooled to 0 
°C.  Triethylamine (0.42 mL, 3.04 mmol) was added dr opwise, followed by the addition of 
freshly distilled methane sulfonyl chloride (0.19 mL, 2.43 mmol).  The reaction was allowed 
to stir overnight while warming to room temperature.  The following day, the reaction was 
quenched by the addition of a saturated NaHCO3 solution.  The layers were separated, and 
the aqueous layer was extracted into CH2Cl2 (2 x 100 mL).  The organic extracts were dried 
(Na2SO4), and evaporated to give a clear crude oil, which was purified by flash 
chromatography (10% EtOAc/hexanes to 20% EtOAc/hexanes) to give 1.10 g of the product 
3.154 (97%).    1H NMR (400 MHz, CDCl3) δ 7.29 (d, J = 7.8, 2H), 6.91 (d, J = 8.4, 1H), 5.82 
(m, 1H), 5.11 (dd, J =16.8, 1 H), 4.54 (d, J = 11.4, 1H), 4.43 (d, J = 11.4, 1H), 4.29 (dd, J = 
9, 9, 1H), 4.21 (m, 1H), 3.89 (m, 1H), 3.83 (s, 3H), 3.71 (dd, J = 7.2, 7.2, 1H), 2.94 (s, 3H), 
2.35 (s, 1H), 2.15 (m, 2H), 1.89 (m, 1H), 1.61 (m, 1H), 1.46 (m, 1H), 1.11 (m, 24H), 0.92 (d, 
7.2, 3H);  13C NMR (150 MHz, CDCl3) δ 159.16, 136.16, 129.43, 117.00, 113.78, 76.06, 
72.06, 70.95, 70.17, 55.27, 40.07, 37.58, 37.05, 31.04, 30.02, 19.00, 18.29, 18.26, 18.23, 
15.74, 12.61; IR (thin film) ν 3411, 2942, 2866, 1641, 1613, 1586, 1513, 1463, 1359, 1302, 
1248, 1177, 1036; [α]22D = -13.1 (c = 12.7, CH2Cl2); MS (ESI) calculated for C29H52O6SSi 








To a solution of mesylate 3.154 (3.21 g, 5.76 mmol) in THF (58 mL) was added a solution of 
lithium triethylborohydride in THF (1.1 M solution, 26.2 mL, 28.2 mmol) dropwise at room 
temperature.  The reaction was stirred overnight.  The following day, the reaction was 
cooled to 0 °C and H 2O was added slowoly dropwise.  Following gas evolution, Et2O (50 mL) 
was added.  The layers were separated, and the aqueous layer was further extracted with 
Et2O (3 x 50 mL).  The organic extracts were dried (MgSO4) and evaporated to give a crude 
clear oil which was purified by flash chromatography (5% EtOAc/hexanes) to afford 2.334 g 
of the product 3.155 (88%), a clear oil.     1H NMR (600 MHz, CDCl3) δ 7.29 (d, J = 4.0, 2H), 
6.90 (d, J = 5.2, 2H), 5.80 (m, 1H), 5.02 (dd, J = 18.6, 18.6, 2H), 4.49 (d, J = 10.8, 1H), 4.43 
(d, J = 11.4, 1H), 3.87 (m, 1H), 3.83 (s, 1H), 3.38 (m, 1H), 2.23 (m, 1H), 1.92 (m, 2H), 1.79 
(m, 1H), 1.67 (m, 1H), 1.27 (m, 1H), 1.09 (m, 23H), 0.94 (m, 6H); 13C NMR (150 MHz, 
CDCl3) δ 159.00, 137.98, 131.27, 129.35, 115.53, 113.68, 81.79, 71.76, 70.67, 55.29, 38.15, 
36.78, 35.39, 31.57, 19.50, 18.30, 18.26, 16.17, 14.78, 12.69; IR (thin film) ν 2942, 2866, 
2360, 1640, 1614, 1513, 1463, 1381, 1301, 1248, 1171, 1040; [α]22D = 1.48 (c = 6.45, 
CH2Cl2); MS (ESI) calculated for C28H50O3Si [M+Na]










 A solution of Weinreb amide 3.49 (1.0 g, 4.48 mmol) in THF (9 mL) was cooled to 0 °C.  A 
solution of freshly prepared vinyl magnesium bromide (1M solution in THF, 22.4 mL, 22.4 
mmol) was added dropwise to the reaction mixture, and allowed to warm to room 
temperature.   After TLC indicated consumption of starting material, the reaction was 
quenched by pouring into a 0 °C 10% HCl solution.  Af ter evolution of gas, the phases were 
separated and the aqueous phase was extracted with EtOAc (3 x 50).  The organic extracts 
were dried (Na2SO4), concentrated, and purified via flash chromatography (10% 
EtOAc/Hexanes) to provide 810 mg of enone 3.50 (95%), a clear oil.     1H NMR (400 MHz, 
CDCl3) δ 7.35 (m, 5H), 6.85 (dd, J =17.2, 10.4, 1H), 6.80 (dd, J =17.6, 10.4, 1H), 5.83 (dd, J 
=10.8, 1.6, 1H), 4.60 (d, J = 11.6, 1H), 4.47 (d, J =11.6, 1H), 4.14 (q, J =6.8, 1H), 1.40 (d, J 
=6.8, 3H); 13C NMR (125 MHz, CDCl3) δ 201.39, 137.50, 130.95, 129.89, 128.49, 127.93, 
127.87, 79.85, 71.84, 17.75; IR (thin film) ν 2981, 1700, 1611, 1454, 1402, 1111; [α]22D = -
4.13 (c = 7.9, CH2Cl2); MS (ESI) calculated for C12H14O2 [M+Na]





To a degassed solution of enone 3.50 (1.36 g, 7.20 mmol) and terminal olefin 3.155 (2.22 g, 
4.80 mmol) in CH2Cl2 (48 mL) was added Hoveyda-Grubbs 2
nd generation catalyst (300 mg, 
0.48 mmol).  The reaction was heated to reflux, and stirred overnight.  The following day, the 
reaction was concentrated to yield a crude black oil which was purified with flash 
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chromatography (100% hexanes to 5% EtOAc/hexanes to 10% EtOAc/hexanes) to provide 
2.10 g of the product 3.156 (70%).  1H NMR (400 MHz, CDCl3) δ 7.27-7.39 (m, 9H), 7.09 
(ddd, J = 7.8, 7.8, 12.6, 1H), 6.90 (d, J =7.8, 2H), 6.56 (d, J =15.6, 1H), 4.60 (d, J = 11.4, 
1H), 4.45 (d, J =10.8, 3H), 4.10 (q, J =6.6, 1H), 3.87 (m, 1H), 3.83 (s, 3H), 3.38 (m, 1H), 
2.43 (m, 1H), 2.15 (m, 1H), 1.97 (m, 1H ), 1.81 (ddd, J = 13.8, 5.4, 5.4, 1H), 1.67 (m, 1H), 
1.39 (d, J =6.6, 3H), 1.36 (m, 1H), 1.10 (m, 22H), 0.97 (d, J =6.6, 3H), 0.92 (d, J =6.6, 3H); 
13C NMR (100 MHz, CDCl3) δ 201.17, 159.08, 148.97, 137.65, 130.96, 129.33, 128.48, 
127.89, 127.87, 125.63, 113.73, 81.68, 79.96, 71.80, 71.79, 70.94, 55.29, 37.95, 35.28, 
31.88, 19.35, 18.30, 18.25, 18.07, 16.05, 15.60, 12.67; IR (thin film) ν 2941, 2865, 1697, 
1622, 1513, 1456, 1381, 1248, 1107; [α]22D = -12.8 (c = 3.5, CH2Cl2); MS (ESI) calculated 
for C38H60NO5Si [M+Na]





A solution of enone 3.156 (2.10 g, 3.36 mmol) in Et2O (34 mL) was cooled to -78 °C.  A 
solution of MeMgBr (3 M in Et2O, 5.6 mL, 16.8 mmol) was added slowly dropwise.  The 
reaction was stirred for 3 h, and quenched by the addition of a saturated solution of NH4Cl. 
The layers were separated and the aqueous layer was then extracted into Et2O (2 x 30 mL).  
The organic extracts were dried (Na2SO4) and evaporated to give a clear crude oil which 
was purified by flash chromatography (10% EtOAc/hexanes) to afford 2.00 g of the tertiary 
alcohol (93%), a clear oil.  1H NMR (600 MHz, CDCl3) δ 7.37 (m, 7H), 6.89 (d, J = 8.4, 2H), 
4.71 (d, J = 10.8, 1H), 4.48 (m, 3H), 3.87 (m, 1H), 3.82 (s, 3H), 3.43 (m, 1H), 3.36 (m, 1H), 
2.56 (s, 1H), 2.23 (m, 1H), 1.93 (m, 2H), 1.79 (m, 1H), 1.66 (m, 1H), 1.29 (s, 4H), 1.18 (d, J 
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=6, 3H), 1.07 (m, 24H), 0.93 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 158.99, 138.56, 133.97, 
131.27, 129.35, 128.63, 128.39, 127.66, 127.63, 113.68, 81.84, 81.52, 74.75, 71.81, 71.32, 
70.65, 55.29, 38.19, 35.78, 35.28, 31.77, 24.63, 19.56, 18.31, 18.26, 16.08, 14.91, 14.12, 
12.70; IR (thin film) ν 3433, 2940, 2866, 1612, 1513, 1462, 1379, 1247, 1071; [α]22D = +14.3 
(c = 3.3, CH2Cl2); MS (ESI) calculated for C39H64O5Si [M+Na]





To a solution of ditertbutylbiphenyl (3.20 g, 12.0 mmol) in THF (17.1 mL) was added pieces 
of Li metal (83 mg, 12.0 mmol).  The solution was sonicated for 2 h at room temperature to 
yield a dark green-blue solution which was used immediately.  A solution of the tertiary 
alcohol (640 mg, 1.00 mmol) in THF (11 mL) was cooled to -78 °C.  A solution of freshly 
prepared LDBB in THF (0.7 M, 15.6 mL, 10.9 mmol) was added dropwise to the reaction.  
After consumption of the starting material by TLC, the reaction was quenched with a 
saturated solution of NH4Cl.  The layers were separated, and the aqueous layer was 
extracted into EtOAc (3 x 25 mL).  The organic extracts were concentrated, and the crude 
solid was purified by flash chromatography (20% EtOAc/hexanes to 40% EtOAc/hexanes) to 
yield 532 mg of a clear oil (97%). 1H NMR (500 MHz, CDCl3) δ 7.28 (d, J = 8, 2H), 6.90 (d, J 
= 8, 2H), 5.75 (dddd, J = 15.5, 7.5, 7.5, 1H), 5.57(d, J = 15.5, 1H), 4.47 (d, J = 11, 1H), 4.44 
(d, J = 11.5, 1H), 3.88 (m,  1H), 3.82 (s, 3H), 3.65 (m, 1H), 3.82 (m, 1H), 3.38 (m, 1H), 2.24 
(m, 1H), 2.02 (s, 1H), 1.99 (m, 2H), 1.89 (m, 1H), 1.81 (m, 1H), 1.64 (m, 1H), 1.28 (m, 4H), 
1.16 (d, J = 6.5, 3H), 1.09 (m, 24H), 0.94 (d, J = 7, 3H), 0.91 (d, J = 6.5, 3H)  5.30 (ddd, J = 
6.8, 6.8, 0, 1H), 5.16 (m, 1H), 3.38 (s, 3H), 3.00 (dd, J = 11.2, 0, 1H), 2.36 (m, 1H), 2.31 (m, 
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1H), 2.21 (m, 1H), 2.04 (m, 1H), 1.69 (d, J = 5.6, 4H), 1.09 (d, J = 6.8, 3H), 1.05 (d, J = 6.8, 
3H), 1.02 (d, J = 6.8, 3H ), 0.89 (d, J = 6.8, 3H); 13C NMR (125 MHz, CDCl3) δ 159.05, 
132.90, 131.14, 130.12, 129.42, 113.68, 81.71, 75.14, 74.28, 71.89, 70.81, 55.27, 38.02, 
35.60, 35.00, 31.85, 24.63, 19.41, 18.30, 18.25, 17.99, 16.02, 15.31, 12.69; IR (thin film) ν 
3419, 2941, 2866, 1613, 1513, 1462, 1379, 1247, 1065; [α]22D = +2.2 (c = 3.5, CH2Cl2); MS 
(ESI) calculated for C32H58O5Si [M+Na]













To a solution of the diol (50 mg, 0.09 mmol) in dimethoxypropane (5 mL) was added CSA (2 
mg, 0.009 mmol).  The reaction was stirred for 20 m, and quenched by the addition of a 
saturated sodium bicarbonate solution.  Ethyl acetate (5 mL) was added and the resultant 
layers separated.  The aqueous layer was further extracted into EtOAc (3 x 5 mL).  The 
organic extracts were dried (Na2SO4), and concentrated to afford a crude oil.  The oil was 
purified with flash chromatography (5% EtOAc/hexanes) to provide 37 mg of the product 
(69%).     1H NMR (600 MHz, CDCl3) δ 5.51 (m, 2H), 7.29 (d, J = 8.4, 2H), 6.89 (dd, J = 6.6, 
2.4, 2H), 5.68 (m, 1H), 5.48 (d, J = 15.6, 1H), 4.48 (d, J =11.4), 4.43 (d, J = 10.8, 1H), 4.01 
(q, J =6, 1H), 3.89 (m, 1H), 3.83 (s, 3H), 3.38 (m, 1H), 2.24 (m, 1H), 1.95 (m, 1H), 1.81 (m, 
1H), 1.68 (m, 1H), 1.52 (s, 3H), 1.43 (s, 3H), 1.35 (s, 3H), 1.31 (m, 1H), 1.19 (d, J = 6.6, 3H), 
1.09 (m, 23H), 0.94 (d, J = 7.2, 3H), 0.92 (d, J = 7.2, 3H);13C NMR (150 MHz, CDCl3) δ 
159.00, 132.35, 131.25, 129.42, 129.33, 113.68, 107.14, 82.33, 81.90, 79.81, 71.83, 70.71, 
55.28, 38.22, 35.81, 35.18, 31.68, 28.33, 26.76, 24.00, 19.46, 18.31, 18.26, 16.11, 15.02, 
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14.98, 12.69; IR (thin film) ν 2940, 2866, 1613, 1587, 1513, 1462, 1376, 1301, 1248, 1213, 
1187, 1097;  [α]22D = 11.1 (c =16, CH2Cl2); MS (ESI) calculated for C35H62O5Si [M+Na]+: 





A solution of the corresponding diol (800 mg, 1.45 mmol) in a 1:1 mixture of anhydrous 
DMSO/CH2Cl2 (5 mL DMSO/ 5 mL CH2Cl2) was cooled to 0 °C.  To this was added Hünig's 
base (2.02 mL, 11.6 mmol) followed by the sulfur trioxide pyridine complex (924 mg, 5.81 
mmol) all in one portion.  The reaction was allowed to warm to room temperature.  Upon 
completion of the reaction by TLC analysis, the reaction was quenched by the addition of a 
saturated NaHCO3 solution.  The layers were separated and the aqueous phase was further 
extracted with CH2Cl2 (2 x 30 mL).  The organic extracts were dried (Na2SO4), concentrated, 
and purified by flash chromatography (10% EtOAc/hexanes to 20% EtOAc/hexanes) to 
provide 550 mg of the product 3.159 (77%)  1H NMR (500 MHz, CDCl3) δ 7.28 (d, J = 9, 2H), 
6.89 (d, J = 9, 2H), 5.87 (m, 1H), 5.56 (d, J = 15.5, 1H), 4.44 (m, 2H), 4.04 (s, 1H), 3.88 (m, 
1H), 3.82 (s, 3H), 3.36 (m, 1H), 2.22 (s, 4H), 1.96 (m, 2H), 1.79 (m, 1H), 1.75 (m, 1H), 1.32 
(m, 1H), 1.09 (s, 26H), 0.91 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 209.82, 159.04, 132.08, 
131.87, 131.15, 129.31, 113.70, 81.75, 78.75, 71.85, 70.78, 55.27, 38.08, 35.64, 34.86, 
31.76, 24.61, 23.60, 19.40, 18.30, 18.24, 16.07, 15.16, 12.69; IR (thin film) ν 3474, 2941, 
2866, 1713, 1613, 1586, 1513, 1462, 1356, 1301, 1247, 1172, 1098; [α]22D = -25.2 (c = 6.9, 
CH2Cl2); MS (ESI) calculated for C32H56O5Si [M+Na]







A solution of ketone 3.159 (190 mg, 0.35 mmol) in CH2Cl2 (4 mL) was cooled to 0 °C.  2,6-
lutidine (0.28 mL, 2.45 mmol) was added dropwise followed by TBSOTf (0.28 mL, 1.21 
mmol).  After TLC analysis indicated the absence of starting material, the reaction was 
quenched by the addition of a saturated NaHCO3 solution.  The layers were separated, and 
the aqueous phase was further extracted with CH2Cl2 (2 x 25 mL).  The organic phase was 
stirred overnight with a 10% HCl solution (25 mL).  The following day, the layers were 
separated.  The aqueous phase was extracted with CH2Cl2 (2 x 25 mL).  The organic 
extracts were dried (Na2SO4), and concentrated to yield a crude oil.  The oil was purified via 
flash chromatography (5% EtOAc/hexanes to 10% EtOAc/hexanes) to provide 175 mg of 
the product 3.160 (76%).  1H NMR (400 MHz, CDCl3) δ 7.29 (d, J =8.8, 2H), 6.90 (d, J = 
10.4, 1H), 5.78 (ddd, J = 14.0, 6.4, 6.4, 1H), 5.47 (d, J =15.6, 1H), 4.48 (m, 2H), 3.88 (m, 
1H), 3.83 (s, 3H), 3.36 (m, 1H), 2.24 (m, 4H), 1.94 (m, 2H), 1.80 (m, 1H), 1.65 (m, 1H), 1.45 
(s, 3H ), 1.32 (m, 1H), 1.09(m, 22H), 0.97(m, 16H), 0.14 (s, 3H), 0.12(s, 3H); 13C NMR (100 
MHz, CDCl3) δ 210.75, 159.03, 133.62, 131.18, 130.90, 129.31, 113.70, 82.28, 81.93, 77.85, 
70.81, 55.26, 38.18, 35.83, 35.00, 31.75, 25.92, 24.65, 24.19, 19.44, 18.20, 18.25, 16.08, 
15.08, 12.69, -2.12, -2.43; IR (thin film) ν 2957, 2865, 2359, 1721, 1613, 1587, 1513, 1463, 
1369, 1349, 1301, 1249, 1171, 1107, 1039, 1013; [α]22D = +32 (c = 2.35, CH2Cl2); MS (ESI) 
calculated for C38H70O5Si2 [M+Na]






A solution of thione 3.63 (3.58 g, 14.3 mmol) in 143 mL CH2Cl2 was cooled to 0 °C.  Neat 
TiCl4 (1.57 mL, 14.3 mmol) was added dropwise, and the resulting slurry was stirred for 15 
min.  The reaction was then cooled to -78 °C and i-Pr2NEt (2.49 mL, 14.3 mmol) was added 
dropwise.  The resulting dark red solution was stirred for 2 h at -78 °C.  A solution of freshly 
prepared 3-butenal (1.00 g, 14.3 mmol) in CH2Cl2 (25 mL) was added dropwise.  After 1 h of 
stirring at -78 °C, the reaction was quenched by additi on of a saturated solution of NH4Cl, 
and the layers were separated.  The aqueous phase was extracted with CH2Cl2 (3 x 25 mL).  
The organic extracts were dried (Na2SO4), and concentrated to afford a crude yellow oil.  
The oil was purified by flash chromatography (10% EtOAc/hexanes) to deliver 1.45 g of the 
product 3.64 (41%), a yellow oil.   1H NMR (500 MHz, CDCl3) δ 7.39 (m, 5H), 5.91 (m, 1H), 
5.44 (m, 1H), 5.21 (m, 1H), 4.29 (m, 1H), 3.70 (dd, J = 2.5, 2.5, 1H), 3.45 (dd, J = 7.5, 11.5, 
1H), 3.26 (m, 2H), 3.09 (dd, J = 10.5, 13, 2H), 2.93 (d, J =11.5), 2.74 (s, 1H), 2.41 (m, 2H); 
13C NMR (125 MHz, CDCl3) δ  201.41, 173.00, 136.40, 134.02, 129.45, 128.96, 127.31, 
118.31, 68.34, 67.26, 45.27, 40.80, 36.82, 32.08; IR (thin film) ν 3432, 2923, 1692, 1495, 
1435, 1342, 1293, 1263, 1192, 1164, 1137, 1044; [α]22D = +103.4 (c = 7.1, CH2Cl2); MS 
(ESI) calculated for C16H19NO2S2 [M+Na]
+: 344.1, found 344.1. 
 
 
Other diastereomer:  
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1H NMR (500 MHz, CDCl3) δ 7.39 (m, 5H), 5.90 (m, 1H), 5.45 (m, 1H), 5.20 (m, 2H), 4.18 
(m, 1H), 3.67 (m, 3H), 3.26 (m, 1H), 2.23 (m, 2H), 2.95 (d, J = 11.5, 1H), 2.41 (m, 2H); 13C 
NMR (125 MHz, CDCl3) δ 201.45, 173.57, 136.35, 134.02, 129.45, 128.97, 127.32, 118.22, 
68.23, 67.90, 44.87, 40.95, 36.79, 32.05; IR (thin film) ν 3423, 1690, 1494, 1342, 1261, 
1163, 1042; [α]22D = +27 (c = 11.1, CH2Cl2); MS (ESI) calculated for C16H19NO2S2 [M+Na]+: 




A solution of secondary alcohol 3.64 (1.89 g, 5.88 mmol) in 58 mL CH2Cl2 was cooled to 0 
°C.  2.6-lutidine (1.36 mL, 11.76 mmol) was added dr opwise, followed by TESOTf (2.00 mL, 
8.83 mmol).  The reaction was warmed to room temperature and quenched by the addition 
of a saturated NaHCO3 solution.  The layers were separated and the aqueous layer was 
then extracted into CH2Cl2 (2 x 30 mL).  The organic extracts were dried (Na2SO4) and 
evaporated to give a crude yellow oil which was purified by flash chromatography (3% 
EtOAc/hexanes) to afford 2.45 g of the product 3.65 (96%), a yellow oil.  1H NMR (500 MHz, 
CDCl3) δ 7.39 (m, 5H), 5.89 (dddd, J = 17, 17, 7, 7, 1H),  5.31(m, 1H), 5.15 (dd, J = 10.5, 9, 
2H), 4.46 (m, 1H), 3.54 (dd, J = 8.5, 17, 1H), 3.39 (dd, J =7, 11.5, 1H), 3.28 (dd, J = 13, 3.5, 
2H), 3.08 (dd, J =11, 11, 1H), 2.92 (d, J = 11.5, 1H), 2.36 (dd, J = 6.5, 13, 2H), 0.99 (t, J = 8, 
9H), 0.66 (q, J = 8, 6H ); 13C NMR (125 MHz, CDCl3) δ 201.05, 172.21, 136.63, 134.23, 
129.46, 128.94, 127.22, 117.91, 68.78, 45.73, 42.44, 36.53, 32.18, 6.91, 5.02; IR (thin film) ν 
2953, 1698, 1455, 1341, 1263, 1190, 1164, 1136, 1092, 1044, 1006; [α]22D = +99 (c = 4, 
CH2Cl2); MS (ESI) calculated for C22H33NO2S2Si [M+Na]






A solution of thione 3.60 (150 mg, 0.54 mmol) in 3 mL CH2Cl2 was cooled to 0 °C.  Neat 
TiCl4 (0.06 mL, 0.54 mmol) was added dropwise, and the resulting slurry was stirred for 5 
min.  The reaction was then cooled to -78 °C and i-Pr2NEt (0.09 mL, 0.54 mmol) in 1 mL of 
CH2Cl2 was added dropwise.  The resulting dark red solution was stirred at -78 °C for 1 h.  
Freshly prepared 3-butenal (0.625 g, 0.357 mmol) was added in 2 mL CH2Cl2.   After 
addition was complete, the reaction was allowed to stir at -78 °C for 1 h, and then  was 
quencedh by the addition of a saturated aqueous NH4Cl solution.  The layers were 
separated and the aqueous layer was then extracted into CH2Cl2 (2 x 10 mL).  The organic 
extracts were dried (Na2SO4) and evaporated to give a crude yellow oil which was purified 
by flash chromatography (10% EtOAc/hexanes to 20% CH2Cl2/hexanes) to afford 85 mg of 
the product 3.61 (69%), a yellow oil.     1H NMR (600 MHz, CDCl3) δ 6.88 (s, 2H), 6.42 (dd, J 
= 10.2, 10.2), 5.83 (dddd, J =0, 16.2, 16.2, 7.3, 1H), 5.13 (dd, J = 0, 13.2), 3.98 (m, 1H), 
3.63 (m, 2H), 3.38 (dd, J =10.8, 10.8, 1H), 3.23 (dd, J = 0, 17.4, 1H), 2.87 (dd, J = 0, 4.2), 
2.42 (s, 6H), 2.32 (m, 5H); 13C NMR (150 MHz, CDCl3) δ 201.76, 174.71, 137.96, 133.95, 
132.65, 118.14, 68.07, 67.78, 45.96, 40.84, 32.56, 20.83; IR (thin film) ν 3436, 2919, 2360, 
1704, 1641, 1610, 1454, 1371, 1325, 1260, 1177, 1128; [α]22D = +87 (c = 5.5, CH2Cl2); MS 
(ESI) calculated for C18H23NO2S2 [M+Na]






A solution of secondary alcohol 3.61 (86 mg, 0.25 mmol) in 6 mL CH2Cl2 was cooled to 0 °C.  
2,6-lutidine (0.06 mL, 0.50 mmol) was added dropwise, followed by TESOTf (0.08 mL, 0.37 
mmol).  The reaction was allowed to warm to room temperature.  Upon consumption of the 
starting material as indicated by TLC analysis, the reaction was quenched by the addition of 
a saturated NaHCO3 solution.  The layers were separated, and the aqueous phase was 
further extracted with CH2Cl2 (2 x 5 mL).  The organic extracts were dried (Na2SO4) and 
evaporated to give a crude yellow oil which was purified by flash chromatography (3% 
EtOAc/hexanes) to afford 110 mg of the product 3.62 (96%), a yellow solid.     1H NMR (600 
MHz, CDCl3) δ 6.40 (dd, J = 10.2, 1H), 5.74 (m, 1H), 4.98 (d, J = 10.2, 1H), 4.84 (d, J = 16.8, 
1H), 4.21 (m, 1H), 3.69 (dd, J = 4.8, 17.4, 1H), 3.38 (dd, J = 10.2, 1H), 3.12 (dd, J = 7.8, 
17.4, 1H), 2.42 (s, 6H), 2.27 (s, 3H), 1.99 (m, 2H);  13C NMR (150 MHz, CDCl3) δ 200.99, 
173.14, 137.87, 134.44, 132.70, 117.26, 68.36, 67.94, 47.28, 41.21, 32.53, 20.78, 6.84, 
4.84; IR (thin film) ν 2954, 2875, 1709, 1611, 1459, 1371, 1311, 1260, 1177, 1126, 1009; 





A solution of TES ether 3.61 (345 mg, 0.74 mmol) in CH2Cl2 (7 mL) was cooled to -78 °C.  A 
solution of i-Bu2AlH (1 M in hexanes, 1.49 mL, 1.49 mmol) was added slowly dropwise.  
Upon disappearance of the yellow from the reaction, the reaction was quenched with a 
saturated sodium/potassium tartrate solution.  Upon warming to room temperature and 
stirring for 1 h, the layers could be separated.  The aqueous layer was further extracted with 
CH2Cl2 (5 mL x 2).  The organic extracts were dried (Na2SO4) and evaporated to give a 
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crude oil which was purified by flash chromatography (5% EtOAc/hexanes) to afford 160 mg 
of the product 3.7 (94%), a clear oil.   Alternative strategy: A solution of TES ether 3.65 (600 
mg, 1.38 mmol) in CH2Cl2 (14 mL) was cooled to -78 °C.  A solution of i-Bu2AlH (1 M in 
hexanes, 2.76 mL, 2.76 mmol) was added slowly dropwise.  Upon disappearance of the 
yellow from the reaction, the reaction was quenched with a saturated sodium/potassium 
tartrate solution.  Upon warming to room temperature and stirring for 1 h, the layers could be 
separated.  The aqueous layer was further extracted with CH2Cl2 (5 mL x 2).  The organic  
extracts were dried (Na2SO4) and evaporated to give a crude oil which was purified by flash 
chromatography (5% EtOAc/hexanes) to afford 317 mg of the product 3.7 (100%), a clear 
oil.     1H NMR (400 MHz, CDCl3) δ 5.51 (m, 2H), 9.82 (dd, J = 2.4, 1H), 5.85 (dddd, J = 16, 
10.8, 7.2, 7.2 1H), 5.12 (m, 2H), 4.32 (dddd, J = 5.6, 5.6, 5.6, 5.6, 1H), 2.56 (m, 2H), 2.34 
(m, 2H), 0.98 (t, J =8, 9H), 0.65 (q, J =7.6, 1H), 13C NMR (100 MHz, CDCl3) δ 201.96, 
133.79, 118.14, 67.61, 50.43, 42.45, 6.79, 4.89; IR (thin film) ν 2956, 2912, 2877, 1726, 
1642, 1459, 1415, 1239, 1102 [α]22D = +15.1 (c = 3, CH2Cl2); MS (ESI) calculated for 
C12H24O2Si [M+H]





To a solution of i-Pr2NH (0.10 mL, 0.72 mmol) in THF (2 mL) at 0 °C was added n-BuLi (0.45 
mL of a 1.6M solution, 0.72 mmol) dropwise.  After stirring 30 min, the reaction was cooled 
to -78 °C and a solution of ketone 3.160 (160 mg, 0.24 mmol) in THF (3 mL) was added 
dropwise.  After stirring 3 h, a solution of aldehyde 3.107 (160 mg, 0.72 mmol) was added 
dropwise.  The reaction was stirred for 3 h at -78 °C, and then quenched with a saturated 
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NH4Cl solution, and warmed to room temperature.  The layers were separated, and the 
aqueous phase was further extracted with EtOAc (3 x 5 mL).  The organic extracts were 
dried (Na2SO4), concentrated, and purified via flash column chromatography (3% 
EtOAc/hexanes) to give 160 mg of the product 3.161 (74%).     1H NMR (600 MHz, CDCl3) 
(of the mixture) δ 7.28 (d, J = 10.2, 2H), 6.90 (d, J = 8.4, 2H), 5.4-5.9 (m, 4H),  5.04-5.15 (m, 
2H), 4.41 (m, 2H), 4.27 (m, 1H), 4.03 (m, 2H), 3.83-3.93 (m, 5H), 3.35 (m, 2H), 2.89 (m, 1H), 
2.72 (m, 1H), 2.21-2.31(m, 4H), 1.74-1.90 (m, 4H ), 1.65 (m, 1H), 1.39-1.52 (m, 7H), 0.92-
1.08 (m, 40H), 0.61-0.67 (m, 6H), 0.104 (m, 6H) ; 13C NMR (150 MHz, CDCl3) δ 213.40, 
159.01, 134.87, 134.78, 134.67, 133.92, 133.33, 131.38, 131.19, 129.32, 129.28, 117.31, 
117.06, 113.70, 97.49, 92.64, 82.19, 81.96, 81.90, 79.86, 71.83, 70.79, 70.73, 69.23, 68.72, 
68.11, 67.44, 64.16, 55.28, 43.91, 43.61, 43.08, 42.60, 42.44, 38.17, 35.80, 35.20, 35.11, 
6.94, 6.91, 6.87, 5.07, 5.00, 4.95, -2.10, -2.25, -2.28; IR (thin film) ν 3519, 2955, 2874, 1720, 
1641, 1613, 1513, 1461, 1380, 1301, 1248, 1097, 1040; [α]22D = +13 (c = 12.1, CH2Cl2); MS 
(ESI) calculated for C50H93O7Si3 [M+Na]






To a solution of 3.161 (60 mg, 0.067 mmol) in a 10:1 mixture of MeOH:THF (3 mL : 0.3 mL) 
at 0 °C  was added PPh3
.HBr (2.3 mg, 0.007 mmol) in 0.2 mL MeOH.  The reaction was 
stirred for 4 h, and then quenched by the addition of a saturated NaHCO3 solution.  Et2O (3 
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mL) was added, and the layers were separated.  The aqueous layer was extracted (3 x 3 
mL), dried over MgSO4, and concentrated to reveal a crude oil which was purified via flash 
chromatography (10% EtOAc/hexanes to 25% EtOAc/hexanes) to afford 35 mg of 3.162 







To a solution of 3.162 (17 mg, 0.021 mmol) and 4 Å molecular sieves in CH2Cl2 (1 mL) was 
added NMO (3 mg, 0.025 mmol) and TPAP (0.07 mg, 0.002 mmol).  The reaction was 
stirred overnight.  The following day, the solvent was evaporated, and the crude product was 
purified via flash chromatography (10% EtOAc/hexanes) to afford 10 mg of 3.163 (60%).  1H 
NMR (600 MHz, CDCl3) δ 7.29 (d, J = 7.8, 2H), 6.90 (d, J = 8.4, 2H), 5.96 (m, 1H), 5.62 (brs, 
2H), 5.19 (m, 1H), 4.48 (d, J =12, 1H), 4.43 (d, J = 10.2, 1H), 3.88 (m, 1H), 3.87 (m, 1H), 
3.84 (s, 3H), 3.93 (s, 4H), 2.45 (m, 4H), 2.21 (m, 2H), 1.80 (m, 2H), 1.77 (m, 1H), 1.61 (m, 
1H), 1.3-1.40 (m, 4H), 1.08 (m, 27H), 0.95 (m, 13 H), 0.13 (m, 6H);  13C NMR (150 MHz, 
CDCl3) δ 207.20, 159.03, 134.87, 133.63, 131.19, 129.63, 129.31, 118.01, 113.71, 104.74, 
82.02, 80.26, 71.85, 70.80, 70.27, 55.29, 52.31, 46.02, 40.28, 38.27, 35.91, 35.24, 31.76, 
26.02, 19.48, 18.32, 18.27, 16.08, 15.29, 12.70, -1.82, -1.88; IR (thin film) ν 3414, 2957, 
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2865, 2359, 1725, 1613, 1513, 1463, 1380, 1301, 1248, 1097, 1039; [α]22D = -8.65 (c = 2, 
CH2Cl2); MS (ESI) calculated for C45H80O7Si2 [M+Na]







A solution of 3.163 (22 mg, 0.03 mmol) in 0.5 mL of THF was cooled to -20 °C.  A solution of 
the Tebbe reagent (0.5 M in toluene, 0.11 mL, 0.06 mmol) was added dropwise.  After 
stirring 10 m at -20 °C, the cooling bath was removed,  and the reaction was warmed to room 
temperature.  After TLC indicated consumption of the starting material (approximately 10 
min), the reaction was quenched with 15% NaOH (1 mL) at -20 °C.  The reaction was 
diluted with Et2O and filtered through a pad of celite.  The organic extracts were dried 
(MgSO4) and concentrated to afford a crude yellow product.  The crude product was purified 
with flash chromatography (5% EtOAc/hexanes) to afford 17 mg of 3.164 (78%).  1H NMR 
(600 MHz, CDCl3) δ 7.29 (d, J =10.2, 2H), 6.90 (d, J = 7.6, 2H), 5.97 (m, 1H), 5.72 (d, J = 
15.6, 1H), 5.65 (m, 1H), 5.14 (d, J = 17.4, 1H), 5.08 (d, J = 10.2), 4.80 (s, 1H), 4.75 (s, 1H), 
4.49 (d, J = 11.4, 1H), 4.43 (d, J = 11.4, 1H), 3.87 (m, 1H), 3.83 (s, 3H), 3.64 (m, 1H), 3.41 
(s, 3H), 3.37 (m, 1H), 2.37-2.44 (m, 2H), 2.19-2.29 (m, 3H), 1.88-1.96 (m, 3H), 1.76 (m, 1H), 
1.66 (m, 1H), 1.28-1.38 (m, 4H), 0.92-1.1 (m, 40H), 0.12 (s, 3H), 0.11 (s, 3H);   13C NMR 
(150 MHz, CDCl3) δ 159.00, 142.94, 135.78, 134.91, 131.26, 129.32, 128.54, 116.89, 
113.69, 109.88, 102.32, 81.99, 80.72, 71.84, 71.48, 70.70, 55.28, 52.24, 40.55, 39.16, 
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38.35, 35.92, 35.35, 31.71, 26.08, 25.96, 22.31, 19.54, 18.48, 18.32, 18.27, 16.06, 15.16, 
12.70, -1.80, -1.85; IR (thin film) ν 3403, 2957, 1613, 1513, 1463, 1380, 1248, 1097; [α]22D = 
-9.5 (c = 5, CH2Cl2); MS (ESI) calculated for C46H82O6Si2 [M+Na]
+: 809.6, found 809.6. 
  
 
(2S,3S)-1-((S)-4-benzyl-2-thioxothiazolidin-3-yl)-3-h ydroxy-2-methylpent-4-en-1-one  
Secondary alcohol 3.55 (1.30 g, 3.27 mmol) was dissolved in 327 mL CH2Cl2 and transferred 
to a sealed tube (1000 mL).  Hoveyda-Grubbs 2nd generation catalyst (205 mg, 0.32 mmol) 
was then added, and a septum was attached.  Ethylene gas was bubbled through the 
reaction for approximately 7 min, and the septum was replaced with a cap for the sealed 
tube.  After 3h, the reaction was quenched utilizing the Galan cleanup procedure.  The 
solvent was removed under reduced pressure to reveal a brown oil which was purified by 
flash column chromatography (20% EtOAc/hexanes to 30% EtOAc/hexanes) to afford 879 
mg of the product 3.91 (84%), a yellow oil.  1H NMR (600 MHz, CDCl3) δ 7.38 (m, 5H), 5.92 
(m, 1H), 5.37 (d, 17.4), 5.29 (m, 2H), 4.47 (m, 1H), 4.34 (dd, J = 6, 6, 1H), 3.44 (dd, J = 7.2, 
11.4, 1H), 3.10 (dd, J = 12, 12, 1H), 2.94 (dd, J = 0, 11.4, 1H), 2.45 (d, J = 6.6, 1H), 1.32 (d, 
J = 6.6, 3H); 13C NMR (150 MHz, CDCl3) δ 202.61, 177.77, 138.47, 129.48, 128.94, 127.27, 
116.97, 76.36, 68.89, 44.47, 36.68, 32.72, 14.69; IR (thin film) ν 3425, 1695, 1454, 1342, 
1262, 1192, 1167, 1135, 1027; [α]22D = +361 (c = 3.5, CH2Cl2); MS (ESI) calculated for 
C16H19NO2S2 [M+Na]







A solution of secondary alcohol 3.91 (1.05 g, 3.27 mmol) in 33 mL CH2Cl2 was cooled to 0 
°C.  2,6-lutidine (0.8 mL, 6.55 mmol) was added foll owed by TBSOTf (1.12 mL, 4.91 mmol).  
The reaction was warmed to room temperature and then quenched by the addition of a 
saturated NaHCO3 solution.  The layers were separated and the aqueous layer was then 
extracted into CH2Cl2 (2 x 15 mL).  The organic extracts were dried (Na2SO4) and 
evaporated to give a crude yellow oil which was purified by flash chromatography (pure 
hexanes to 5% EtOAc/hexanes) to afford 1.15 g of the product (81%), a yellow oil.     1H 
NMR (600 MHz, CDCl3) δ 7.39 (m, 5H), 5.74 (m, 1H), 5.25 (m, 3H), 4.37 (dd, J = 0, 5.4, 2H), 
3.37 (m, 2H), 3.10 (dd, J = 12, 12, 1H), 2.92 (dd, J = 0, 11.4, 1H), 1.15 (d, J = 4.8, 1H), 0.86 
(s, 9H), 0.06 (s, 3H), 0.04 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 201.17, 177.27, 139.11, 
136.74, 129.49, 128.93, 127.17, 117.65, 78.49, 69.11, 45.62, 36.55, 32.33, 25.77, 17.97, 
14.26, -3.90, -4.93; IR (thin film) ν 3027, 2954, 2884, 2856, 2360, 2341, 1697, 1603, 1495, 
1455, 1361, 1341, 1293, 1260, 1192, 1167, 1133, 1057, 1027; [α]22D = +207 (c = 21.2, 
CH2Cl2); MS (ESI) calculated for C22H33NO2S2Si [M+H]




A solution of the TBS ether (770 mg, 1.61 mmol) in 16 mL CH2Cl2 was cooled to -78 °C.  i-
Bu2AlH (1M solution, 3.22 mL, 3.22 mmol) was added dropwise until the solution was 
colorless.  The reaction was then quenched by the addition of a saturated Na/K tartrate 
solution, and warmed to room temperature.  The layers were then separated, and the 
aqueous layer was extracted with CH2Cl2 (3 x 5 mL).  The organic extracts were dried 
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(Na2SO4) and evaporated to give a crude oil which was purified by flash chromatography 
(5% EtOAc/hexanes) to afford 354 mg of aldehyde 3.92 (88%), a colorless oil, which was 
used directly in the next reaction.  1H NMR (300 MHz, CDCl3) δ 9.77 (s, 1H), 5.88 (m, 1H), 
5.27 (m, 2H), 4.32 (dd, J = 6.3, 6.3, 1H), 2.53 (m, 1H), 1.08 (d, J = 10, 3H), 0.88 (s, 9H), 







tert-butyl((3S,4R)-6,6-dibromo-4-methylhexa-1,5-die n-3-yloxy)dimethylsilane   
A solution of aldehyde 3.92 (312mg, 1.37 mmol) in 14 mL THF was cooled to -78 °C .  PPh3 
(762 mg, 2.90 mmol) was added, followed by CBr4 (481 mg, 1.45 mmol) in THF (2 mL).  The 
reaction was warmed to -50 °C and stirred for 8 h.  A fter TLC analysis indicated completion 
of the reaction, pentanes (20 mL) was added.  The solvent was reduced until a precipitate 
was formed, and was filtered through a plug of silica.  The crude oil was purified via flash 
column chromatography (pure hexanes) to reveal 355 mg of the product (68%).  1H NMR 
(500 MHz, CDCl3) δ 6.32 (d, J = 9.5, 1H), 5.79 (ddd, J = 6, 10, 17, 1H), 5.21 (d, J =17.5, 1H), 
5.15 (d, J =10, 1H), 4.03 (dd, J = 5.5, 1H), 2.61 (m, 1H), 1.02 (d, J =7, 3H), 0.93 (s, 9H), 
0.08 (s, 3H), 0.04 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 140.71, 139.16, 115.67, 88.37, 
76.10, 45.00, 25.82, 18.15, 15.05, -4.29, -4.90; IR (thin film) ν 2929, 2857, 1471, 1254, 






(4R,5S)-methyl 5-(tert-butyldimethylsilyloxy)-4-met hylhept-6-en-2-ynoate 
A solution of the dibromide (355 mg, 0.93 mmol) in 10 mL THF was cooled to -78 °C.  n-
BuLi (1.3M solution, 2.86 mL, 3.72 mmol) was added dropwise and stirred for 30 min.  
Methyl orthoformate (0.4 mL, 5.12 mmol) was added dropwise.  The reaction was warmed to 
room temperature.  After TLC analysis indicated completion of the reaction, the reaction was 
quenched by the addition of a saturated aqueous NH4Cl solution.  The layers were 
separated and the aqueous layer was then extracted into EtOAc (2 x 15 mL).  The organic 
extracts were dried (Na2SO4) and evaporated to give a crude oil which was purified by flash 
chromatography (pure hexanes to 3% EtOAc/hexanes) to afford 145 mg of the product 3.93 
(55%), a colorless oil.  1H NMR (400 MHz, CDCl3) δ 5.91 (ddd, J =6, 10, 16.5, 1H), 5.30 (d, J 
= 17, 1H), 5.22 (d, J =10.5, 1H), 4.20 (dd, J =5.5, 5.5, 1H), 3.78 (s, 3H), 2.73 (dq, J =6.5, 
6.5, 6.5, 6.5, 1H), 1.18 (d, J = 7.5, 3H), 0.92 (s, 9H), 0.10 (s, 3H), 0.06 (s, 3H) 13C NMR (125 
MHz, CDCl3) δ 154.24, 137.64, 116.64, 91.10, 75.27, 74.16, 52.54, 33.40, 25.74, 18.16, 
14.52, -4.52, -5.03; IR (thin film) ν 2955, 2857, 2237, 1719, 1472, 1434, 1361, 1255, 1137, 
1089, 1033; [α]22D = -6.08 (c = 2.25, CH2Cl2); MS (ESI) calculated for C15H26O3Si [M+Na]+: 
305.1, found 305.1. 
 
 
(4R,5S,Z)-methyl 5-(tert-butyldimethylsilyloxy)-3,4 -dimethylhepta-2,6-dienoate 
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To a suspension of CuI (152 mg, 0.80 mmol) in THF (1.6 mL) at 0 °C, was added MeLi (1.6 
M solution in diethyl ether, 0.99 mL, 1.59 mmol).  The reaction was stirred for 15 min at 0 °C 
and then cooled to -78 °C.  Ynoate 3.93 (45 mg, 0.16 mmol) was added in 1.6 mL of THF.  
The reaction was transferred to a -50 °C bath, and st irred for 4 hThe reaction was then 
quenched by the addition of a saturated aqueous NH4Cl solution.  The layers were 
separated and the aqueous layer was then extracted into EtOAc (3 x 4 mL).  The organic 
extracts were dried (Na2SO4) and evaporated to give a crude oil which was purified by flash 
chromatography (5% EtOAc/hexanes) to afford 35 mg of the product 3.89 (75%), a colorless 
oil.  1H NMR (400 MHz, CDCl3) δ 5.81 (m, 2H), 5.19 (m, 2H), 4.10 (m, 2H), 3.69 (s, 3H), 1.87 
(d, J = 1.2, 3H), 1.03 (d, J =6.8, 3H), 0.88 (s, 9H), 0.06 (s, 3H), 0.02 (s, 3H);  13C NMR (150 
MHz, CDCl3) δ 166.72, 162.16, 140.27, 117.30, 115.31, 50.72, 40.10, 25.77, 21.20, 18.10, 
15.06, -3.90, -5.08; IR (thin film) ν 3397, 2956, 2857, 1722, 1641, 1434, 1378, 1254, 1224, 
1157, 1078; [α]22D = -41.3 (c = 2.9, CH2Cl2); MS (ESI) calculated for C16H30O3Si [M+Na]+: 
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